Wantstats
IndustriesCompaniesCharts & Stats
Leads DBAdvisoryPricingContact us
Login
/Company Profiles

Deep Intelligence Across Industries

All CompaniesFortune 500Aerospace & Defense iconAerospace & DefenseAgricultureAutomotive iconAutomotiveFinancial Services iconFinancial ServicesChemicals & Materials iconChemicals & MaterialsConsumer Goods iconConsumer GoodsEnergy & Power iconEnergy & PowerEquipment & Machinery iconEquipment & MachineryFood & Beverages iconFood & BeveragesHealthcare & Pharma iconHealthcare & PharmaInformation Technology iconInformation TechnologyManufacturing & ConstructionMRO iconMROProfessional Services iconProfessional ServicesSemiconductors

Showing 14441 companies

Carbonxt

Carbonxt Group Limited

Premium
Information Technology

Carbonxt is a micro-cap, US-focused cleantech manufacturer of specialised activated carbon (AC), listed in Australia but operated from Gainesville, Florida. It sells powdered activated carbon (PAC) and activated carbon pellets (ACP) to industrial customers that must capture mercury, sulphur compounds and other contaminants from flue gas and process streams: waste-to-energy operators, coal-fired utilities, cement kilns, industrial boilers and, increasingly, water and wastewater treaters. Its point of difference is a renewable, wood-waste-derived PAC made at its Black Birch, Georgia plant, and its claim to be the only US manufacturer of industrial AC pellets (Minnesota). The investment case now rests on a 49.4%-owned joint-venture plant in Inez, Kentucky (NewCarbon Processing, LLC). Management forecasts that plant will lift group sales about 200% and move Carbonxt into the far larger liquid-phase market driven by US PFAS drinking-water rules. That plant is late, however, and the balance sheet is highly geared and covenant-dependent. --- ### Company's own description In its FY26 results release (31 Aug 2026), Carbonxt describes itself as a cleantech company that develops and markets specialised activated carbon products. Its focus is capturing contaminants in industrial processes that emit large quantities of harmful pollutants. It produces and manufactures PAC and AC pellets for industrial air purification, wastewater treatment and other liquid- and gas-phase markets. MarketScreener's company profile adds that the company specialises in oxidising, non-brominated activated carbons. These are positioned as non-corrosive, avoiding the equipment deterioration associated with heavily brominated carbons used in mercury capture. ### Independent characterisation Carbonxt is best understood as a niche specialty-chemicals manufacturer in transition. It is moving from an air-phase emissions-control business with roughly A$15–16m of revenue towards a liquid-phase, PFAS-exposed water-treatment business. **What it sells:** Two product families make up all reported revenue: - **PAC (powdered activated carbon).** Made at Black Birch, Georgia from reclaimed sawmill wood waste. It is injected into flue-gas streams, mainly at waste-to-energy (WTE) plants, to capture mercury and other pollutants. PAC was 53% of FY26 revenue and 66% of FY26 volume (FY26 results). FY26 was the first year PAC made up a majority of revenue. - **ACP (activated carbon pellets).** Made at Arden Hills, Minnesota (now being relocated to a cheaper site). Pellets are used in fixed-bed systems, notably in multi-pollutant control systems at utilities and industrial sites. Pellets were 70% of revenue in FY22, 65% in FY23 and 59% in FY24. They fell to about 47% in FY26 after industrial pellet sales were "largely ceased", leaving a focus on higher-value contaminant-reduction pellets. **Revenue model:** 100% product sales (manufactured goods) under a mix of multi-year supply contracts and purchase orders. There is no subscription, licensing or service revenue of significance. Small grant income has been recognised in some years (for example FY24 grant revenue of A$615k for nutrient-reduction and red-tide research). **Contract structure:** Core volumes sit under long-term contracts: - Reworld PAC contract: 4 years from 1 October 2024, about A$24m in total, about A$6m a year, supplying 17 US WTE plants. - A principal ACP customer contract extended for three years in FY26 at higher prices and better payment terms (expected annual revenue from that contract up more than 30%). - Earlier one-off orders, such as Wisconsin Public Service (WPS): a A$4.3m pellet order in May 2024, paid upfront. **Value-chain position:** Carbonxt is a converter. It buys or sources carbonaceous feedstock (wood waste for PAC; bagged input material for pellets — the FY26 release notes pellet output depends on bagged material from Black Birch), activates and processes it, and sells it to end users. It does not own feedstock sources and has no downstream treatment-services business. The Kentucky JV adds a kiln-based activation plant (initial capacity 10,000 tonnes a year) on a former waste-to-energy power-station site. **Customer types:** WTE operators (Reworld being the anchor), coal-fired and other utilities (for example WPS), cement plants, industrial boilers, and water/wastewater treatment operators (target market via Kentucky). **End markets:** 1. US air-phase emissions control (mercury, acid gases; regulated under MACT/MATS-type rules). 2. US liquid-phase water treatment, including PFAS removal under the April 2024 EPA drinking-water standards. 3. Smaller niche R&D applications (red-tide/nutrient control in Florida with Mote Marine Laboratory). **Geography:** All operations and substantially all revenue are in the United States, while the corporate shell, listing, capital providers and most shareholders are in Australia. This creates a structural A$/US$ translation exposure: FY26 revenue fell 3.1% in A$ but rose 1.4% in US$.

Revenue$0.0B
EmployeesN/A
Market CapN/A
Founded2001
Sydney, Australia

Unlock Verified Contacts

Access verified employee contacts

Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.

USD650/mo
Buy Now

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
MR
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
BL
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
MI
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
RK
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
JL
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
AM
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Wantstats logo

Move faster. Think smarter. Win bigger.

Join our data driven community.

© 2026 All rights reserved by Wantstats Research and Media Pvt Ltd

footer vector

Pages

  • About
  • News
  • Charts & Stats
  • Contact
  • Ecosystem pricing
  • Privacy policy

Address

Wantstats Research and media Pvt. Ltd, Office No 104, Pentagon 4,
Magarpatta City, Pune - 411028,
Maharashtra, India.

Contact

support@wantstats.com

Follow Us

Follow Wantstats on FacebookFollow Wantstats on InstagramFollow Wantstats on LinkedInFollow Wantstats on YouTubeFollow Wantstats on WhatsApp
Carbon

Carbon Minerals Limited

Premium
Information Technology

| Field | Supplied in request | Verified / current position | Comment | |---|---|---|---| | Legal name | Carbon Minerals Limited | Carbon Minerals Limited (ABN 29 001 836 586) | Confirmed (FY2011 Annual Report) | | Country | Australia | Australia (incorporated and domiciled in NSW) | Confirmed | | Exchange | Australian Securities Exchange | Formerly ASX; removed from Official List 14 Feb 2024 | Delisted, now unlisted public company | | Ticker | CRM.AX | ASX: CRM (inactive since delisting) | Ticker no longer trades | | ISIN | CA79467F1062 | — | The "CA" prefix denotes a Canadian-issued security and cannot belong to an Australian-incorporated company. Australian ISINs begin with "AU". The supplied ISIN appears to be a data error in the source list. The correct AU ISIN is not publicly disclosed in sources reviewed. | | Website | http://www.carbonminerals.com.au | Domain cited in company filings; Market Index lists website as "-" | Site status not confirmed; likely inactive or unmaintained | **Entity profiled:** Carbon Minerals Limited, the same legal entity that was ASX-listed. It has not changed its name since converting from a no-liability company. No successor listed entity exists. ### Core corporate data | Item | Detail | Source | |---|---|---| | Legal name | Carbon Minerals Limited | FY2011 Annual Report | | Former names | Carbon Minerals NL (ASX codes CRMCA from 20/06/2007, CRM from 06/10/2008) | Market Index corporate record | | Founding year | 1980. Formation sponsored via Magnum Explorations Limited; chairman's tenure dates from 25 January 1980 | FY2011 Annual Report (Chairman's address) | | Incorporation jurisdiction | New South Wales, Australia | FY2011 Annual Report | | Registered office (last disclosed in primary filing) | Level 7, 10 Barrack Street, Sydney NSW 2000 | FY2011 Annual Report; 2012 quarterlies | | Operations / technical office (historic) | Suite 2.06, 56 Delhi Road, North Ryde NSW 2113 (office of technical adviser Earth Resources Australia Pty Ltd) | 2012 quarterly reports | | Exchange / ticker | ASX: CRM (suspended 9 Feb 2022; delisted 14 Feb 2024) | InvestSMART, BusinessNews | | Date listed per Market Index | 18 Aug 2008 | Market Index. This reflects re-coding after the NL-to-Limited conversion; the company was listed well before 2008, as it traded via 1980s–1990s capital events. | | ISIN / CUSIP | Not publicly disclosed in sources reviewed (supplied ISIN invalid for this entity) | — | | Fiscal year end | 31 December | All annual reports | | Employees | Nil. The company disclosed that it had no employees; the board performed management functions. | FY2011 Corporate Governance Statement | | Employee trend (3-year) | Nil throughout (no evidence of change) | — | | Auditor | PricewaterhouseCoopers (Sydney) | FY2011 Annual Report; Market Index (current record) | | Share registry | Mitchell & Partners (2011). Market Index currently lists Computershare. A "Details of Share Registry address" notice was lodged 7 Feb 2022. | Discrepancy noted | | Shares on issue | 18,803,498 ordinary shares (unchanged FY2010–FY2022) | FY2011 AR; Market Index FY2022 | | Market capitalisation | Last indicative: AUD 5.83M at AUD 0.31/share (FY2021–FY2022 per Morningstar). No current market value exists post-delisting. | Market Index | | Ultimate controlling entity (2011) | Malewi Investments Pty Limited (Lincoln Smith family) | FY2011 AR Note 20 | | Majority shareholder group | Lincoln Smith interests: 80.81% (15,195,997 shares) as at 21 Mar 2023 | Market Index substantial holder data | Carbon Minerals Limited is a family-controlled Sydney exploration holding company. Its value rests on one asset: a 35% carried and participating interest, held through wholly owned subsidiary Australian Coalbed Methane Pty Limited (ACM), in Petroleum Exploration Licences 1 and 12 in the Gunnedah Basin of northern NSW. Santos QNT Pty Ltd holds the other 65% and operates. The company pioneered CSG exploration in the basin from 1992 and identified a biogenic gas fairway in 2004. It brought in Santos through a 2007 farm-in, then monetised 40% of the project for AUD 15 million in 2011. The licences were renewed in April 2022 for six years, to April 2028. With no revenue, a treasury of roughly AUD 2.7 million and an 81% controlling holder, the company chose not to remediate its suspension and accepted ASX delisting in February 2024. Its residual value is effectively an option on Santos advancing Gunnedah Basin gas, adjacent to the Narrabri Gas Project. --- ### What the company does Carbon Minerals Limited is a natural resources exploration holding company. Its activities have three parts: 1. **Holding a minority non-operated interest in CSG exploration tenements.** ACM holds 35% of PEL 1 and PEL 12. Santos QNT Pty Ltd holds 65% and is operator under a joint venture. 2. **Funding its share of joint-venture expenditure and administering the listed or unlisted corporate shell.** 3. **Minor primary production.** It grew crops on vacant freehold land, the "Glasserton" property south-south-east of Gunnedah, which the company owns. This was reported as a separate "Primary production" segment. The company describes its principal continuing activity as exploration for natural resources in the Commonwealth of Australia (FY2011 Annual Report, Directors' Report). Data aggregators summarise it as a seam gas exploration and development company with its interest in the Gunnedah Basin CSG project (AnnualReports.com and Market Index company descriptions). ### Business model and revenue model | Revenue element | Nature | Materiality | |---|---|---| | Interest income on cash and term deposits | Passive treasury income | Main recurring income; AUD 253,413 in FY2011, about AUD 0.02M in FY2022 | | Technical and administration fees | Recoveries from JV activity | AUD 78,000 in FY2011 | | Access compensation | Land access payments | AUD 3,000 in FY2011 | | Crop sales (primary production) | Agricultural use of owned land | Immaterial; segment result was a loss | | Asset monetisation (non-recurring) | Sale of tenement equity | AUD 15M cash received in FY2011 (gain AUD 12.86M) | **Mix:** There are no product, service, subscription or licensing revenues. The model is "exploration-and-farm-out." Value is created by de-risking acreage and sold or carried through farm-ins, rather than through operating revenue. ### Value-chain position and end-markets **Value-chain position:** Upstream, pre-development exploration. Non-operator, minority equity holder. **Ultimate end-market (if developed):** East Australian domestic gas market, NSW in particular. NSW imports most of its gas from other states. **Customers:** None at present. A future buyer of any produced gas would most plausibly be Santos itself or NSW domestic gas buyers via Santos marketing. **Independent characterisation:** The company functions as a royalty-like option on Santos' Gunnedah Basin programme. Its economics are hostage to three things: Santos' capital allocation, NSW CSG policy, and native title and community licence-to-operate. It has no operational control and no operating cash flows. The controlling shareholder appears comfortable holding the asset privately rather than funding listed-company compliance.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1980
Sydney, Australia
Carboclor

Carboclor S.A.

Premium
Information Technology

Carboclor S.A. is a 106-year-old Argentine company that has turned from a petrochemical solvents producer into a specialised liquid-bulk port, storage and logistics terminal. The terminal sits at Campana, on the Paraná de las Palmas river within the Zárate–Campana industrial corridor of Buenos Aires province. It has been controlled since 2003 by ANCSOL S.A., part of Uruguay's state energy group ANCAP. Its business is tank rental and the services around it: ship, barge, truck and container loading and discharge, drum filling, customs-bonded export tanks, and steam, nitrogen, air and water utilities. These serve agro-industrial exporters (oleins, tallow, fatty acids), fuel traders and chemical distributors. Tariffs are set in US dollars, while most costs are peso-denominated and inflation-indexed. The company emerged from a 2016–2023 court-supervised creditor reorganisation with no financial debt and about ARS 4.8bn of cash. It is a micro-cap with a thin free float: on FY2025 figures, revenue is about ARS 16.4bn, roughly US$11m. --- **Company's own description.** The FY2025 filing describes Carboclor's principal activity as providing port, storage and logistics services. Its statutory corporate purpose is broader: it covers the production and marketing of chemical, petrochemical and petroleum-derived products as well as port, storage and logistics services [A]. The board's governance report states the mission as creating sustainable economic value in the strategic units of port services, storage and logistics. It names five critical success factors: staff involvement, continuous innovation, portfolio diversification, resource productivity and positioning of the Carboclor brand [A]. **Business model.** Carboclor runs an independent (third-party) liquid-bulk terminal. Revenue comes almost entirely from services, recognised over time under IFRS 15 [A]. It has three main components: 1. **Storage (tank rental).** Capacity is contracted by product segment. Volume handled under tank rental was about 324 thousand m³ in FY2025, down from 481 thousand m³ in FY2024 [A]. 2. **Throughput and handling.** This covers ship and barge berthing, truck loading and discharge, and container and drum filling. The terminal served 60 vessels in FY2025 [A]. 3. **Ancillary and utility services.** These include steam heating (critical for fatty products), nitrogen blanketing, compressed air and water, plus a customs information system for the port terminal [A], [F]. There is no product, subscription or licensing revenue. The remaining legacy chemical activity is classified as discontinued operations: dismantling of inactive petrochemical installations, carried out to free space for new tanks [B]. **Revenue model mix (FY2025).** **Pricing.** Tariffs are dollar-denominated because the storage market is tied to foreign trade. The average USD price rose 9.3% year on year in FY2025 [A]. The main earnings sensitivity is the gap between peso inflation, which drives a cost base indexed to chemical and petrochemical union wage settlements, and the pace of peso devaluation, which drives peso revenue [A]. **Value-chain position.** Carboclor is a midstream logistics node. It sits between producers and traders of liquids and ocean or river transport, and owns no cargo. Its customers keep title to the product. **Customer types and end-markets.** Source: [A] FY2025 Memoria. **Independent characterisation.** Carboclor is now in effect a single-asset infrastructure company. It has a sizeable land bank and tank farm on a deep-water river frontage, a very small operating team and a fortress balance sheet. Its economics resemble a small toll-road: high fixed costs, dollar-linked tariffs and operating leverage to occupancy. Its strategic weight lies mainly in its land and waterfront optionality and in its controlling shareholder's intentions. ANCAP has evaluated a sale more than once (2016 and 2021) [A], [D].

RevenueN/A
Employees65
Market CapN/A
Founded1920
United States, North America
Caravel

Caravel Minerals Limited

Premium
Information Technology

Caravel Minerals is a Perth-based, ASX-listed copper developer whose sole material asset is the 100%-owned Caravel Copper Project in Western Australia's Wheatbelt, roughly 150 km north-east of Perth. The project hosts a Mineral Resource of 1.28 billion tonnes at 0.24% Cu for 3.03 Mt of contained copper and an Ore Reserve (June 2026) of 597 Mt at 0.24% Cu for 1.42 Mt of copper, making it one of Australia's largest undeveloped copper deposits by contained metal. The company is completing a Definitive Feasibility Study (DFS), now scheduled for Q4 2026, for a long-life (25+ year), bulk-tonnage open-pit operation targeting about 65,000 tpa of copper in concentrate with gold, silver and molybdenum credits. Its investment case rests on tier-one jurisdiction, freehold farmland setting near grid power, roads and ports, and leverage to copper prices. Its central challenge is financing a capital cost likely above A$1.7 billion from a sub-A$150 million market capitalisation. --- ### Company's own description The FY2026 Annual Financial Report describes the principal activity of the group as "the exploration of mineral tenements in Western Australia". The company's website describes itself as progressing "Australia's largest undeveloped copper project". The Caravel Copper Project is presented in company materials as a +25-year copper development project targeting approximately 65,000 tonnes of contained copper, 15,000 ounces of gold and 660,000 ounces of silver per annum (ASX announcement, 15 June 2026). Note 4.3 of the FY2026 accounts states the group has no material operating segments, no customers, and that all assets and liabilities relate to the mining industry and are located within Australia. ### Independent characterisation Caravel is a single-asset, pre-revenue mine developer at the late-feasibility stage. Its business today is the conversion of a large, low-grade porphyry copper resource into a bankable project, and its "product" in the near term is de-risking: geological confidence (Ore Reserve), engineering definition (DFS), permits (environmental approval under Part IV of the WA Environmental Protection Act 1986), land and water access, power connection, offtake, and a funding package. Value is created (or destroyed) by milestones, not by earnings. The deposit style — Archaean porphyry copper systems formed around 2.7 billion years ago in the Yilgarn Craton, per the 2022 AGM presentation — is geologically unusual for Western Australia. Grades are low (0.24% Cu average reserve), which means project economics depend on very large throughput (about 30 Mtpa ore), low strip ratios, efficient comminution and flotation, and copper price. The location on cleared agricultural freehold land near existing infrastructure is a structural advantage versus remote greenfield copper projects in the Americas or Africa. ### Business and revenue model | Dimension | Current state (FY2026) | Planned state (post-FID, per company disclosures) | |---|---|---| | Revenue model | Nil operating revenue; other income from interest and government grants/R&D incentives (A$1.29M FY2026) | Sale of copper concentrate (with payable gold and silver) and a separate molybdenum concentrate | | Product vs service mix | n/m | 100% physical commodity product | | Customer type | None | Smelters/traders; non-binding MOU with Kutch Copper Ltd (Adani Enterprises subsidiary) for up to 100% of copper concentrate, life of mine | | End-markets | None | Copper smelting and refining, ultimately serving electrical, construction, power-grid, EV and electronics demand | | Value-chain position | Explorer/developer | Upstream miner and concentrator; no smelting or refining | | Funding model | Equity placements, Regal loan facility, royalty sales | Project finance (ECA-backed senior debt), strategic/JV equity, streaming/royalty, offtake prepayment, equity | ### Project technical summary (key operating parameters disclosed) | Parameter | Disclosed figure | Source | |---|---|---| | Location | ~150 km NE of Perth, Wheatbelt WA (note: FY2026 AR Note 3.1 states 120 km; most company announcements state 150 km) | ASX 13 Aug 2026; FY2026 AR | | Ownership | 100% | ASX announcements | | Mineral Resource | 1.28 Bt at 0.24% Cu for 3.03 Mt Cu (inclusive of reserves) | ASX 13 Nov 2023 MRE, restated 2026 | | Ore Reserve (1 June 2026) | 597 Mt at 0.24% Cu for 1.42 Mt Cu, 0.10% Cu cut-off | ASX 19 Jun 2026 | | Proven Reserve | 156 Mt at 0.25% Cu (≈48% more Proven tonnes than 2022 maiden reserve) | ASX 13 Aug 2026 | | Probable Reserve | 441 Mt at 0.23% Cu | ASX 13 Aug 2026 | | Bindi deposit reserve | 506 Mt at 0.23% Cu for 1.18 Mt Cu | ASX 17 Jul 2026 | | Dasher deposit reserve | 91 Mt at 0.26% Cu for 237 kt Cu | ASX 17 Jul 2026 | | Mining method | Conventional open pit, truck and shovel; ultra-class fleet; tier-one contractor for pre-strip and early mining, transitioning to owner mining; autonomous-haulage-ready | DFS mining study (Mining Plus), ASX 17 Jul 2026 | | Pre-strip | ~20 months before first ore to primary crusher | ASX 17 Jul 2026 | | Throughput (design basis) | ~30 Mtpa single-train layout (replacing PFS dual-train 27.8 Mtpa) | Shaw and Partners, 9 Jul 2026 | | Target production | ~65,000 tpa Cu in concentrate; ~15 koz Au and ~660 koz Ag per annum; ~0.9 ktpa Mo by-product | ASX 15 Jun 2026; Shaw 9 Jul 2026 | | Payable copper range (early years) | 62,000–71,000 tpa | Reporting on Adani MOU, Nov 2025 | | Water demand | Reduced from 18 GL/yr to 12 GL/yr | ASX 13 Aug 2026 | | Water source | Saline groundwater, Gillingarra Borefield (Yarragadee and Leederville aquifers) | ASX 18 Sep 2026 | | Power | South-West Interconnected System (SWIS) grid, supplemented by behind-the-meter generation; preliminary access offer from Western Power (Oct 2025) | Shaw 9 Jul 2026; news Oct 2025 | | Key tenure | Mining Lease M70/1425 granted (Bindi), March quarter 2026 | Quarterly report, 30 Apr 2026 | | Mine life | 25+ years (company); 26 years (2023 PFS update); 28 years (2022 PFS) | Various |

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2006
Subiaco, Australia
Cann

Cann Group Limited

Premium
Information Technology

Cann Group was the first company in Australia to receive medicinal cannabis research and cultivation licences, in February and March 2017. It remains one of the country's few vertically integrated, GMP-certified producers of dried cannabis flower at industrial scale. Its core asset is a glasshouse cultivation and GMP manufacturing facility near Mildura, Victoria. It was built for about A$115–120m and designed for more than 12,500kg of dried flower a year, but it ran at roughly half of fitted capacity in FY26, producing 4.6 tonnes. After a near-insolvency episode in 2024–25, the company completed a balance-sheet reset in December 2025. It discharged A$70.6m of National Australia Bank debt for A$15.3m, refinanced with a private credit fund and raised A$9.0m of equity. Revenue has nonetheless fallen for two years, to A$8.6m in FY26. The investment case now rests on export conversion (UK first, Germany next), utilisation of under-used GMP capacity, and possible strategic or M&A outcomes in a consolidating sector. --- ### Company's own description The FY26 announcements describe the business as follows (paraphrased). Cann aims to improve patients' lives by developing, producing and supplying innovative cannabis medicines. It operates a large-scale cultivation and GMP manufacturing facility with integrated research capability near Mildura, Victoria. Through its Botanitech and Mallee Bloom brands, plus bulk and white-label supply, it sells dried flower, oil, vape and edible medicinal cannabis products to customers in Australia and abroad (FY26 Results Announcement, 31 Aug 2026). Earlier boilerplate (FY25 to Nov 2025) also referred to active pharmaceutical ingredients, extracts and the Satipharm patent-protected capsule technology. ### Independent characterisation Cann is in practice a single-asset, cultivation-led medicinal cannabis manufacturer with an increasingly B2B mix. Revenue comes almost entirely from product sales: A$8.551m of A$8.563m in FY26. Services, mainly contract packing, contributed only A$0.012m in FY26, down from A$0.162m in FY25 (Appendix 4E Note 1). The business model has moved through three phases: **2017–2021:** a licence-holder and R&D platform. Revenue was negligible (A$0.56m in FY18), and Aurora-supplied product was used to serve the first patients. **2022–2024:** a capex-heavy scale-up at Mildura funded by NAB construction debt. Revenue came from white-label oils, bulk and branded flower, alongside heavy losses. **2025–present:** a restructured, cost-reset producer. Management has deliberately stepped back from low-margin white-label oil manufacturing and low-priced bulk channels to prioritise branded flower, B2B wholesale with minimum order quantities, and exports. ### Revenue model mix (FY26, Appendix 4E and FY26 results) | Revenue type | FY26 A$m | Share of revenue | Comment | |---|---|---|---| | Product sales: dried flower | 7.7 | 90% | Botanitech (own-grown and curated), Mallee Bloom, bulk and white-label flower | | Product sales: oils | 0.5 | 6% | Legacy white-label and branded oils, being de-emphasised | | Product sales: other (vapes, gummies, capsules) | about 0.35 (derived residual) | about 4% | Not separately disclosed | | Services (contract packing) | 0.012 | <1% | GMP contract packing and white-label capability | | Total revenue from customer contracts | 8.563 | 100% | — | | Other income (R&D tax incentive and grants; other) | 1.089 | n/a | Not counted in revenue | Subscription and licensing revenue: none disclosed. ### Value-chain position Cann covers most of the value chain: - genetics and breeding, including in-house strains La Bomba Ese and Lazer Fuel (AGM 2025); - tissue culture and mother-stock management; - cultivation; - post-harvest work (drying, with a move to a GMP hang-dry process, trimming and irradiation); - GMP packing. For formulated products, it has historically relied on third-party contract manufacturers such as IDT Australia. Downstream it sells to: - wholesalers and distributors (bulk); - brand owners (white label); - prescriber-pharmacy channels in Australia under the TGA framework (Special Access Scheme / Authorised Prescriber pathways); - export importers in the UK, New Zealand and, prospectively, Germany and the wider EU. ### Customer types and end-markets **Domestic B2B wholesalers and distributors:** the largest channel by volume in FY26. Three customers each exceeded 10% of revenue, up from one in FY25. **Domestic pharmacy and patient (B2C brand) channel:** Botanitech and Mallee Bloom, including supply agreements with 11 Chemist Warehouse outlets in Queensland on an initial two-year term (TipRanks summary of ASX release). **Export importers:** UK (A$1.0m in FY26, the first year), New Zealand (A$0.36m) and Germany. AMRadV irradiation-related licences were secured in Q3 FY26 to support German and EU distribution. **End-markets:** prescribed medicinal cannabis for chronic pain, anxiety, sleep and other indications under physician supervision.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2014
Koorlong, Australia
CannGlobal

Cann Global Limited

Premium
Information Technology

Cann Global Limited is a Sydney-based micro-cap that turned a dormant bauxite explorer (Queensland Bauxite) into a diversified hemp, plant-based food, cosmeceutical and medicinal cannabis group between 2016 and 2019. At its peak it had a hemp-seed and chia health-food wholesale business (T12 Holdings / Organic Markets Direct, sold into Costco Australia and exported to Vietnam), a 55%-owned Thai hemp cultivation and extraction services venture, a 50:50 medicinal-tablet JV with Canada's Canntab Therapeutics, a 50:50 skincare JV with Israel's Pharmocann (later the Fuss Pot brand), and Technion-linked multiple sclerosis research. It never reached scale. Revenue peaked at A$1.78m in FY2020 and fell to A$0.56m in FY2022. Cumulative losses reached A$50.7m, funded by repeated, highly dilutive equity raisings. A prolonged voluntary suspension from September 2022 tied to an unconsummated Thailand acquisition, unpaid ASX fees and unlodged FY2023 accounts led to removal from the ASX in March 2024. It now survives only as a registered unlisted shell-like entity. --- **Company's own description (FY2021/FY2022 filings, paraphrased).** Cann Global described itself as a medicinal cannabis and natural food and beauty products business operating in the health and wellness industry. It stressed partnerships with specialists in Australia, the USA, Israel, Asia and Canada, and said it worked within relevant legislation to give practitioners, patients and consumers access to safe, effective and sustainable products [4E-FY21]. The FY2022 financial statements describe the group as a for-profit entity engaged mainly in the legal growing and cultivation of hemp and medicinal cannabis products and in mineral exploration in Australia [4E-FY22]. **Operating divisions as presented to investors (FY2020–FY2022):** 1. **Food (Health Foods)** — hemp seed and chia products (seed, oil, protein, flour, capsules, by-products, smoothie blends) through T12 Holdings / Organic Markets Direct and the Vitahemp, EM Super Foods, Australian Grown Naturals, Black Bag and later Grass Roots brands. This was the only consistent revenue generator. 2. **Hemp Cultivation & Processing** — hemp hulling in Australia (Hemp Hulling Co (QLD) Pty Ltd, 55%) and broad-acre CBD hemp services in Asia through Cann Global Thailand (55%) and Cann Global Asia (55%). 3. **Skincare / Cosmeceutical** — premium hemp-seed-oil skincare first developed in the 50:50 Pharmocann JV, later sold under the wholly owned Fuss Pot brand after the JV was dissolved in July 2022. 4. **Medicine** — the Canntab Therapeutics Australia JV (50:50), which imported pharmaceutical-grade CBD hard tablets (later branded Instacann, using SMEDDS technology) via the TGA Special Access Scheme B and Authorised Prescriber pathways, plus MS-focused cannabis research with Technion (Israel) and NICM. 5. **Mining** — the residual South Johnstone bauxite project, Queensland (EPM 18463, later referenced as MDL 2004), carried at A$2.28m. **Revenue model.** Revenue was almost entirely product sales (goods transferred at a point in time). In FY2022, goods made up A$537.5k of A$562.3k (95.6%); services were A$7.6k and management/rent recharges A$17.3k [4E-FY22]. There was no subscription or licensing revenue. Thai cultivation services (FY2020 services revenue A$151.2k) and a Thai "plant-funding" investor model (FY2022 liability A$254.8k) were the only service-type streams. **Value-chain position.** The company's main role was mid-stream wholesale and branding of commodity health foods, buying seed and sub-contracting farmers rather than growing at scale. In FY2021 it suspended its own hemp-seed cultivation and seed-bank breeding programme in favour of contract farming [4E-FY21]. In medicinal cannabis it was a downstream importer/distributor of a partner's product, not a licensed manufacturer. **Customer types and end-markets.** Retail (Costco Australia; direct-to-consumer web stores), wholesale/white-label distributors, export distributors (Epco Food Co, Vietnam), equine feed (white label), Thai licensed cultivators (AA Bio Co Ltd, Green Pharma Botanical), a US seed buyer (Naga Organics LLC), and prescribing doctors/pharmacies via the TGA access schemes. **Independent characterisation.** Cann Global was a sub-scale holding company with many small, loosely connected ventures across three continents and no defensible core asset. Its corporate overhead (A$3.5–4.2m a year in the corporate segment, FY2020–FY2022) was 2–7 times group revenue. The business depended on related-party service arrangements (Australian Gemstone Mining Pty Ltd, controlled by the founder) and on frequent, deeply discounted equity issues. It was effectively a cash shell with a modest food distribution business attached by FY2022. At 30 June 2022, cash of A$9.24m was about 97% of net assets [4E-FY22].

Revenue$0.0B
EmployeesN/A
Market CapN/A
Founded2007
Sydney, Australia
Camuzzi

Camuzzi Gas Pampeana S.A.

Premium
Information Technology

Camuzzi Gas Pampeana is one of Argentina's nine regulated natural-gas distribution licensees created in the 1992 privatization of Gas del Estado, and, together with sister company Camuzzi Gas del Sur, forms the Camuzzi platform — by the group's own description the country's largest gas distributor by volume, infrastructure and geographic reach. Pampeana serves roughly 1.4 million customers across the interior of Buenos Aires Province (outside the city and Greater Buenos Aires) and La Pampa, an agro-industrial heartland with significant power-generation and industrial loads. It operates under a price-cap licence regulated by ENARGAS, earning a distribution margin while passing through gas and transport costs. After nearly two decades of tariff freezes, the 2025 five-year tariff review (RQT 2025–2030) restored monthly indexation and a capex-backed tariff base, enabling a return to capital markets after 20 years. The equity story now hinges on licence renewal to 2047, execution of the mandatory investment plan, and the parent's LNG del Plata export project. --- **What the company does.** CGP holds an exclusive public-service licence to distribute natural gas by pipeline in its concession area: the interior of Buenos Aires Province (excluding the City of Buenos Aires and the Greater Buenos Aires conurbation, which are served by Metrogas and Naturgy BAN) and the Province of La Pampa. Rava's legacy company profile (based on older company data) describes the area as covering major urban and industrial centres, with service to more than 70% of roughly 1.35 million dwellings in the region, more than 4,500 km of gas pipelines and 20,100 km of distribution networks and branch lines. These network figures are dated; current Pampeana-only network length is not disclosed in the sources reviewed. At the May 2025 ENARGAS public hearing, the company's commercial director stated that Pampeana serves about 1.4 million users, including almost 70,000 commercial customers and 145 large users (EconoJournal, May 2025). Some localities are served with undiluted propane through networks, for which ENARGAS sets separate tariff tables (ENARGAS Res. 638/2025 recitals). **Business model.** CGP is a regulated, asset-based "wires-and-pipes" utility. Customer bills bundle three components: (i) the gas commodity price (PIST), purchased from producers and passed through; (ii) firm transport capacity contracted with transporters TGS and TGN, also passed through; and (iii) the distribution margin (Costo Propio de Distribución / Valor Agregado de Distribución), which is the company's genuine earnings driver. Under the RQT approved in April–May 2025, the distribution margin is set under a price-cap methodology using a regulatory capital base, with a monthly adjustment formula linked to economic indicators and a mandatory five-year investment plan (ENARGAS Res. 262/2025). **Revenue model mix.** CGP's revenue is effectively 100% regulated service revenue — no product, subscription or licensing businesses. Per the Rava summary of the FY2025 financial statements, 85.4% of revenue came from gas sales (bundled service to captive customers), with the balance from transport and/or distribution-only services (for large users who buy gas directly from producers) and "other" concepts. In H1 2026, gas sales were 84.8%, transport/distribution services 13.7%, and other items the remainder; billing by customer type was 73% residential, 18% commercial and the rest industrial (Rava summary of H1 2026 filing). A material share of revenue is government-funded: subsidies represented 21.6% of total sales revenue in H1 2026 versus 22.3% in H1 2025. **Value-chain position.** Downstream end of the Argentine gas chain: producers (Vaca Muerta/Neuquén, Austral, Bolivia historically) → transporters (TGS, TGN) → distributors (CGP) → end users. CGP has no upstream or transport assets of its own beyond high-pressure distribution trunk lines and regulating stations. **Customer types and end-markets.** Residential (R1–R4 categories, plus subsidized beneficiaries), commercial/SME (P categories), large industrial users (agro-processing, food, metals in the Bahía Blanca–La Plata–Mar del Plata axis), CNG stations, and thermal power plants. Volume mix differs sharply from billing mix: in H1 2026, residential accounted for 38% of dispatched volume, industry 29.8% and power plants 15.8% (Rava summary of H1 2026 filing). Industry volume fell 38% year on year in H1 2026, consistent with winter supply curtailments. **Company self-description vs independent characterization.** The group presents itself as Argentina's largest gas distributor by volume and territorial reach, covering 45% of the national territory with two contiguous regions (EconoJournal, April 2026; sustainability report, July 2026). Independently, CGP is best characterized as a mid-sized, low-leverage, regulatory-recovery equity: its economics were crushed by 2002–2023 tariff freezes and are now re-rating as monthly indexation and real-terms margin increases (14.5%–18% real CPD increases for the Metrogas/Litoral/Pampeana cohort, per iProfesional) feed through, offset by heavy mandatory capex, rising collection risk, and an increasingly dollarized debt book.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1992
Ciudad Autónoma de Buenos Aires, Argentina
Calima

Calima Energy Limited

Premium
Information Technology

Calima Energy Limited is a Perth-domiciled, formerly ASX-listed oil and gas company. From 2017 to 2024 it built and then fully monetised a portfolio in the Western Canadian Sedimentary Basin (WCSB). It entered through a 2017 backdoor listing focused on Montney acreage in north-east British Columbia. In April 2021 it became a producer by acquiring Blackspur Oil Corp., a conventional, oil-weighted Alberta producer at Brooks and Thorsby. That business peaked at about 4,046 boe/d of sales in FY2023 and A$122.5 million of oil and gas sales in FY2022. The board concluded that the ASX persistently valued the company below the intrinsic value of its Canadian assets. It therefore sold the Montney position (2023), Blackspur (C$75 million, February 2024) and the residual Paradise field (C$1.2 million, October 2024). It returned about A$90 million in capital, bought back shares, and delisted in December 2024. Calima today is best characterised as an unlisted, asset-less corporate shell with a stated, but unexecuted, intention to acquire new oil and gas assets. --- ### Company's own description (latest annual report, FY2023) The FY2023 Annual Report describes Calima as a production-focused energy company pursuing exploration and development of oil and natural gas assets in the Western Canadian Sedimentary Basin. It states that, after the Blackspur and Montney sales, the company's focus had shifted to maintaining production from the Paradise Field in British Columbia and acquiring additional oil and gas assets. The report put the Paradise field's free cash flow at about A$350,000 a year and post-distribution cash at about A$5–6 million. The September 2024 sale announcement for Calima Energy Inc. repeated that, after the sale and buy-backs, Calima "will continue to focus on the acquisition of further oil and gas assets" (Sale of Calima Energy Inc, ASX release, 10 Sept 2024). ### Independent characterisation Calima's corporate life has had four distinct business models: 1. **2006–2017 (Rialto Energy / Azonto Petroleum): frontier exploration shell.** An ASX junior pursuing international exploration. 2. **2017–2021 (Calima, Montney phase): pre-revenue exploration and appraisal.** The company earned into and later consolidated a Montney land position in north-east British Columbia (63,103 acres by April 2020). In April 2020 it bought the Tommy Lakes compression, pipeline and infrastructure from Enerplus to give the acreage a route to market. 3. **2021–2024 (Blackspur phase): conventional E&P producer.** After the April 2021 Blackspur acquisition, Calima was an operator of oil-weighted conventional wells in southern Alberta (Brooks: Sunburst and Glauconitic formations) and central Alberta (Thorsby: Sparky formation). Revenue came from selling crude oil, natural gas and NGLs at Canadian hub-linked prices, partly hedged. 4. **2024–present: cash shell / delisted company.** After the full divestment and capital returns, the company has no disclosed operating assets. ### Revenue model | Revenue model component | FY2022 (A$k) | FY2023 (A$k) | Share of FY2023 product sales | |---|---|---|---| | Oil sales | 101,606 | 80,170 | 85.9% | | Natural gas sales | 18,269 | 10,640 | 11.4% | | NGL sales | 2,590 | 2,556 | 2.7% | | Total oil and gas sales | 122,465 | 93,366 | 100% | | Service / subscription / licensing | 0 | 0 | 0% | During its producing years, almost all revenue came from product sales: physical oil, gas and NGL volumes sold to integrated producers, midstream and downstream companies, and energy traders. Sales were recognised at the point of delivery, with payment typically within 30 days of the month of delivery (FY2023 Annual Report, revenue recognition policy). There was no service, subscription or licensing revenue. Blackspur owned a proprietary regenerative H2S-removal technology, but no licensing revenue from it was ever disclosed. *Source: FY2023 Annual Report, Operational and Financial Results.* ### Value-chain position, customers and end-markets **Value-chain position:** Upstream (exploration, development, production). The company owned some gathering infrastructure, including a Brooks-area pipeline built in 2022 and the Tommy Lakes facilities from 2020 to 2023. It had no refining or marketing integration. **Customer types:** The FY2023 Annual Report says the customer base consisted primarily of integrated oil and natural gas producers, midstream and downstream companies, and energy traders. At 31 December 2023 most receivables were held with four investment-grade counterparties. **End-markets:** North American crude and gas markets, priced off Edmonton, Western Canadian Select (WCS) and Cushing (WTI) benchmarks and Canadian gas hubs (FY2023 reserves assumptions).

RevenueN/A
EmployeesN/A
Market Cap$0.0B
Founded2005
West Leederville, Australia
Cadence

Cadence Capital Limited

Premium
Information Technology

Cadence Capital Limited is a Sydney-based listed investment company that offers ASX investors exposure to a concentrated, actively managed, long-biased portfolio of Australian and international equities run by Cadence Asset Management under founder Karl Siegling. Its distinctive process combines fundamental stock selection with technical (price-trend) analysis and a disciplined entry/exit and position-scaling regime, which lets the manager move rapidly between sectors and hold large cash balances — an average of roughly 25% since inception, per the company. The vehicle can short-sell and use derivatives for hedging, and it sits in the "absolute-return-minded, high-conviction" niche of the A$50bn-plus Australian LIC market. Its shareholder proposition centres on fully franked dividends funded from a profits reserve, monthly transparency and strong insider alignment (the Chairman's interests hold 12.85%). After a weak FY2018–FY2025 stretch, the fund returned 20.1% in FY2026 against 5.7% for the All Ordinaries Accumulation Index. --- **Company's own description.** The FY2026 Annual Report states that the Company's principal activity is investing primarily in securities listed in Australia and internationally, that it may take short positions, and that it may deal in derivatives for hedging; no significant change in that activity occurred during the year. Note 19 states the Company has a single segment, operates predominantly in Australia in the securities industry, and derives revenue from dividends, interest and the sale of financial assets measured at fair value, while carrying foreign exposure through internationally listed securities. **Independent characterisation.** CDM is a closed-end, permanent-capital investment vehicle. Its "business" is the portfolio. Economic value per share is driven by (i) gross portfolio returns, (ii) the cost of the external management agreement (1% p.a. of gross portfolio value plus a 20% performance fee over the All Ordinaries Accumulation Index, with an absolute-return condition), (iii) tax effects (it carries a large deferred tax asset of A$59.3m, mostly accumulated tax losses), and (iv) the share price's premium or discount to NTA, which the board manages with DRP-neutralising buy-backs. **Investment process (as described by the manager).** The Cadence process blends fundamental screening (valuation, earnings momentum, balance sheet) with technical trend analysis and a rules-based scaling approach: positions are built as price trends confirm and are cut when trends break. This produces high turnover — purchases of A$543.0m and sales of A$696.6m in FY2026 against average net assets near A$300m (FY2026 Annual Report, cash flow statement) — and large swings in net exposure (net long exposure was 76.5% of equity at 30 June 2024 versus 30.2% at 30 June 2022). **Revenue model (LIC equivalent).** Source: FY2022, FY2024 and FY2026 Annual Reports (statements of profit or loss). There is no product/service/subscription/licensing mix in the operating-company sense. Income is overwhelmingly mark-to-market capital gains (91% of FY2026 income), with dividend income collapsing in FY2026 as the portfolio rotated out of yield stocks into cash. **Value-chain position.** CDM is the capital provider; Cadence Asset Management is the service provider (investment management, company secretarial, ASX/ASIC liaison, accounting at A$6,820 per month plus A$9,900 per half-/full-year set of accounts). BNP Paribas provides leverage, stock lending and custody; Boardroom runs the register. **Customer types / end-markets.** Shareholders are predominantly retail and self-managed superannuation fund (SMSF) investors, frequently via platforms (HUB24, Netwealth nominee lines appear in the top 20). Top-20 holders own only 24.6% of capital (31 August 2026), and no institutional holder appears among substantial holders. The "end-market" invested in is ASX-listed equities (with episodic US, Canadian and Korean exposure — e.g., Samsung Electronics in FY2026).

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2005
Sydney, Australia
Buxton

Buxton Resources Limited

Premium
Information Technology

Buxton Resources is a Perth-based, micro-capitalisation mineral explorer. It has no producing assets and no recurring operating revenue. Since a strategic review in March 2025, it has concentrated capital on 100%-owned, large-system copper-gold targets in Western Australia's under-explored desert provinces. The Madman Cu-Au project in the Paterson Orogen is a Havieron-style magnetic "bullseye". The Centurion IOCG target and Lateron intrusive-hosted Cu-Au targets lie in the Kimberley/Great Sandy Desert region. Buxton also retains about 30.5 km² of unencumbered copper-porphyry ground in Arizona around the Copper Wolf system. It sold its 49% JV interest in Copper Wolf to IGO in June 2026 for about A$6.15M. That sale gave Buxton its first statutory profit in years (FY2026 NPAT A$1.17M) and a cash balance of A$7.26M. Optionality remains in a 20.7 Mt graphite resource (Graphite Bull) and free-carried nickel JV interests with IGO. The investment case is binary and discovery-driven. The near-term catalyst is drill hole MD004DD, which was targeting an untested EM conductor at Madman in October 2026. --- ### Company's own description In the FY2026 Annual Report, the board describes its principal activities as acquiring mining tenements and exploring and evaluating them, with the objective of identifying economic mineral deposits. The FY2026 Review of Operations frames the year as one of executing the March 2025 strategy. That strategy has two parts: - concentrating on 100%-owned copper-gold projects large enough to yield transformational discovery returns; - opportunistically monetising JV interests and non-core positions. The company's investor profile (Stockhead) describes Buxton as focused on discovering and developing metalliferous ore deposits (nickel, copper, gold, iron and graphite). It lists past milestones: a greenfields discovery that defined a new magmatic Ni-Cu sulphide province in the West Kimberley, a high-grade graphite resource at Graphite Bull, and a magnetite resource at Zanthus. It also notes that this grassroots success led to several farm-in JV agreements with IGO Limited. ### Business model and revenue model Buxton follows the classic prospect-generator / discovery-explorer model: 1. **Generative work.** The company identifies geophysical anomalies, often from open-file magnetic and gravity data and Magnetic Vector Inversion modelling, in under-explored covered terrains. It then pegs ground cheaply, frequently on unclaimed Crown land. 2. **Value-add.** It secures Native Title and heritage agreements, completes geophysics, and obtains Exploration Incentive Scheme (EIS) co-funding for maiden drilling. 3. **Monetisation**, through three routes: - farm-outs to majors that fund exploration (IGO in the West Kimberley, Fraser Range and Copper Wolf); - outright asset sales (Copper Wolf JV interest, FY2026); - in a success case, discovery-driven re-rating or corporate takeover. The company has no product, service or subscription revenue in the conventional sense. Its "revenue and other income" is lumpy and non-recurring. FY2026 income of A$6.78M was made up of: - asset-sale proceeds (87%); - government grants and R&D tax incentives; - JV partner contributions; - small geological-services fees (A$418k in FY2026, earned by providing services under contract); - tenement rent refunds and interest. The FY2026 Annual Report sets out separate revenue-recognition policies for disposal of exploration interests, JV contributions, geological services, R&D incentives and interest. ### Value-chain position, customers and end-markets Buxton sits at the earliest, highest-risk end of the mining value chain: greenfields exploration ahead of resource definition, feasibility, development and production. It has no customers in the conventional sense. Its effective counterparties are: **mid-tier and major miners:** that buy or farm into its projects (IGO is the dominant counterparty historically); **governments:** (WA Department of Energy, Mines, Industry Regulation and Safety — DEMIRS — through EIS grants; the Australian Tax Office through R&D incentives); **equity investors:** (domestic institutions and sophisticated investors through Argonaut Securities and Taylor Collison; UK sophisticated investors through SI Capital). The end-markets its commodities would ultimately serve are copper and gold (primary focus), nickel and cobalt (JV interests), and natural flake graphite for lithium-ion battery anodes (Graphite Bull). ### Independent characterisation Buxton is best characterised as a cash-shell-plus-options exploration vehicle with an unusually strong farm-out track record relative to its size. Over about a decade it has repeatedly converted cheaply pegged ground into partner-funded programs, and it has now achieved an outright cash exit (Copper Wolf). The company's value is almost entirely its post-sale cash (A$7.26M at 30 June 2026, plus A$1.136M raised in July 2026) plus the option value of a handful of deep, covered, high-impact drill targets. Governance and capital-structure features also shape the investment case: - a three-person board; - heavy reliance on equity placements; - around 57.3M unlisted options outstanding. The March 2025 pivot under Chair Gervaise Heddle (former Greatland Gold CEO through the Havieron discovery) explicitly reorients Buxton toward a "Havieron-style" discovery thesis.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2007
Belmont, Australia
BTCHealth

BTC Health Limited

Premium
Information Technology

| Field | Detail | |---|---| | Legal name | BTC Health Limited (styled "BTC health Limited" in some filings) | | Former name | Biotech Capital Limited | | ABN / ACN | ABN 45 091 979 172 / ACN 091 979 172 | | Incorporated | 14 March 2000 (per TradingView company profile; consistent with ACN series) | | Incorporation jurisdiction | Australia (public company limited by shares, domiciled in Australia — FY2026 Annual Report, Note 1) | | Legal / tax status | Registered Pooled Development Fund under the *Pooled Development Funds Act 1992* (Cth) | | Accounting status | Investment entity under AASB 10; investees held at fair value through profit or loss (Level 3) | | Headquarters / registered office | Level 1, 10 Oxley Road, Hawthorn VIC 3122, Australia | | Previous office (data-provider records) | Suite 201, 697 Burke Road, Camberwell VIC 3124 | | Exchange / ticker | Australian Securities Exchange, ASX: BTC (Yahoo/Reuters-style: BTC.AX) | | ISIN | AU000000BTC7 | | Other identifiers | FIGI BBG000C028N0; German WKN 552817 | | CUSIP | Not applicable / not publicly disclosed (Australian security) | | Fiscal year end | 30 June | | Ordinary shares on issue | 357,454,456 (30 June 2026 and 14 August 2026) | | Unlisted options | 21,000,000 | | Shareholders | 981 holders (14 August 2026) | | Auditor | RSM Australia Partners (Melbourne), lead partner A L Whittingham. Appointed at the 28 November 2025 AGM after a competitive tender, replacing Grant Thornton Audit Pty Ltd. | | Share registry | Link Market Services Limited, Melbourne | | Employees | Not publicly disclosed in the annual report. Third-party directory lists 11–50 employees across the group (annualreports.co.uk). | | Market capitalisation | Approx. A$20–21 million. Based on a last observed share price of A$0.057–0.060 (InvestSMART, August 2026) × 357.45m shares. The live price as at 9 October 2026 should be verified. | | Website | www.btchealth.com.au | | Executive Chairman & Managing Director | Dr Richard Treagus | | CFO & Company Secretary | Salesh Balak | | Chief Operating Officer | Joshua Kahanovitz | No change of listing or ticker has occurred. | Metric | FY2024 | FY2025 | FY2026 | |---|---|---|---| | Group employees (number) | — | — | — | **Not publicly disclosed.** The annual report does not state a headcount. The KMP disclosure covers 5 individuals (3 directors, CFO and COO). BTC Health is a micro-cap, Melbourne-based specialty medical-products distribution group wrapped inside a tax-advantaged Pooled Development Fund structure. Through three wholly owned investee companies — BTC Cardio, BTC Speciality Health and BTC Pharma — it in-licenses and distributes imported medical devices, consumables and specialty pharmaceuticals into Australian and New Zealand public and private hospitals. Its focus areas are cardiothoracic surgery, ECMO/critical care, post-operative pain, neuro-spinal procedures and respiratory medicine. Group revenue was A$10.27m in FY2026 (unaudited). Since 2024 the business has pivoted decisively towards cardiac and critical care, anchored by the January 2025 takeover of Corcym's ANZ heart-valve business. Cardio now represents 57% of revenue. The group is near break-even at EBITDA level, debt-free, and dependent on exclusive supplier agreements and hospital procurement cycles. Its investment case rests on four things: converting a large ECMO evaluation pipeline, rebuilding infusion-pump volumes, managing supply risk from a now-insolvent pharmaceutical manufacturer, and the PDF's tax-free capital-gains treatment for shareholders. --- ### The company's own description The FY2026 Annual Report and every recent ASX release use the same self-description. BTC Health describes itself as a Pooled Development Fund that actively invests in businesses which acquire, develop and distribute innovative medical products in Australia and New Zealand. It says it is building a group of high-growth businesses that together give access to some of the best specialised therapeutics and medical devices from around the world. The FY2026 Directors' Report states its principal activity as follows: the company is a PDF registered under the PDF Act 1992 and invests in entities in the healthcare sector. It held direct interests in three investee companies at 30 June 2026 and continues to seek investment opportunities in healthcare. The FY26 Investor Presentation adds the PDF rationale. PDFs exist to increase the supply of capital to SMEs. PDFs are taxed at 15% on income and gains from SME equity investments. Shareholders are exempt from tax on income and gains from holding and disposing of PDF shares. ### Independent characterisation Stripped of the PDF wrapper, BTC Health is an asset-light, exclusive-agency medical device and specialty pharmaceutical distributor for the ANZ market. Its key characteristics are: 1. **No proprietary manufacturing and no meaningful R&D.** Products are sourced from overseas or domestic manufacturers under exclusive or semi-exclusive distribution agreements. Examples include Corcym (Italy/UK), Eurosets (Italy), Exstent (UK), Micrel (Greece), IZI Medical (USA), Ilumark (Germany), Morpheus AG, Andocor NV (Belgium), SmartCanula LLC, Jafron Biomedical (China/HK) and Arna Pharma (Sydney). 2. **Value-add is regulatory and commercial.** BTC acts as Australian sponsor (TGA registration, ARTG listings and pharmacovigilance). It manages reimbursement — Prescribed List of Medical Devices for devices and the PBS for Bronchitol. It also handles hospital tendering, clinical evaluations, field clinical support, inventory holding and logistics. 3. **The customer base is concentrated in hospitals.** This means State public hospital systems (via purchase orders and tenders), private hospitals and specialist clinicians: cardiothoracic surgeons, perfusionists, intensivists, anaesthetists, interventional radiologists and respiratory physicians. 4. **The model has three layers.** The listed parent is a holding vehicle that funds working capital via interest-free loans (A$1.90m outstanding to BTC Cardio at 30 June 2026). The investees carry the operating P&L. Value is recognised at the parent through directors' DCF valuations. ### Revenue model | Revenue type | Share of group revenue | Comment | |---|---|---| | Product sales — implantable / single-use medical devices | Majority (Cardio 57% plus Neurospinal 13% in FY2026) | Heart valves, PEARS implants, cannulas, biopsy needles, markers, bone removal devices | | Product sales — capital equipment | Included in Cardio (ECMO A$1.60m in FY2026) | Eurosets ECMO consoles and systems; lumpy, tender-driven | | Product sales — consumables / disposables | Included in Infusion Pumps (19%) and Cardio | Elastomeric and electronic pump disposables, oxygenators, circuits | | Specialty pharmaceuticals | 11% (FY2026) | Bronchitol (PBS-listed) and Aridol | | Royalty income | Immaterial / not separately disclosed | Single-digit royalty from Arna Pharma on Singapore/Malaysia sales for 3 years from February 2025 (now at risk given Arna's administration) | | Services, subscription, licensing-out | Nil disclosed | — | | Statutory parent revenue | Interest income only: A$29,419 in FY2026 | Parent records no product revenue | ### Value-chain position BTC sits in the downstream commercialisation and distribution layer: > Manufacturer (offshore OEM) → [BTC: in-licensing, regulatory sponsorship, reimbursement listing, importation, warehousing, sales/clinical support] → Hospital procurement (State health purchasing bodies / private hospital groups) → Clinician / patient ### Customer types and end-markets | Customer type | End-market / clinical area | Investee | |---|---|---| | Public tertiary hospitals (cardiothoracic units, ICUs, paediatric hospitals) | Cardiac surgery, ECMO / extracorporeal life support, critical care, hemoperfusion | BTC Cardio | | Private hospitals | Cardiac surgery (valves, PEARS), post-operative pain | BTC Cardio, BTC Speciality Health | | Surgical / anaesthesia departments | Post-operative pain management (elastomeric and electronic ambulatory infusion pumps) | BTC Speciality Health | | Interventional radiology / spine | Tissue biopsy, image-guided surgery markers, bone removal | BTC Speciality Health | | Respiratory physicians, cystic fibrosis clinics, lung function labs; community and hospital pharmacy | Cystic fibrosis therapy (Bronchitol); bronchial challenge testing (Aridol) | BTC Pharma | **Geography:** Australia and New Zealand only (FY2026 Annual Report, Note 3 — single segment, single geography: Australia).

Revenue$0.0B
EmployeesN/A
Market CapN/A
Founded2000
Hawthorn, Australia
Broo

Broo Limited

Premium
Information Technology

Broo Ltd is a micro-capitalisation Australian beer brand owner that listed on the ASX in October 2016 on a twin thesis: building an independent, "Aussie-patriotic" mainstream lager franchise (Broo Premium Lager and Australia Draught) in the domestic market, and exporting the brand at scale into China through contract brewing and a take-or-pay distribution agreement. Neither leg delivered. The China agreements generated no reported revenue and were terminated in January 2021; the flagship "world's greenest brewery" project in Ballarat never reached a planning application and the land was repurchased by the State in December 2022. After a shareholder-driven board spill in 2022, the operating subsidiaries (Mildura Brewery, Mildura Brewery Pub, Australia Draught, Sorrento Brewery) were placed into administration and liquidation. Broo recorded zero revenue in FY2023, net liabilities of A$6.7 million, and was removed from the ASX in May 2024. It is today best characterised as a dormant, balance-sheet-insolvent shell holding residual brand rights. --- ### Company's own description In its FY2023 Annual Report, the board described the group's principal continuing activity as the production and distribution of beer products. The directors' report characterised the period as one of overcoming a liquidity crisis and heavy debt through a strategic overhaul, leadership change, streamlined operations and supply chain review, and stated the company was nearing final arrangements for ongoing product supply with manufacturers. It also announced the creation of a new beer brand intended to "rejuvenate" the Broo franchise. The going-concern note quantified the ambition: launch of the new brand was planned for February 2024, with estimated revenue of A$1.8 million per year (FY2023 Annual Report, Note 1). Earlier descriptions (pre-2022, via Morningstar and Investing.com company profiles drawn from filings) described Broo as engaged in the development, sale and distribution of beer in Australia and China, and in the management of pub and boutique brewery venues, reporting through two segments: Hospitality (pubs and boutique brewery venues) and Australian Brewing (production and sale of packaged beer in Australia), with the majority of revenue from Australian Brewing. The lead product, Broo Premium Lager, was described as a full-flavoured, full-strength lager in a 375 ml amber bottle. ### Independent characterisation Broo's business model evolved through three distinct phases: **Phase 1 — Brand owner with outsourced production (2009–2016).** Founder Kent Grogan built Broo as a marketing-led brand, notably offering shares to purchasers of cartons ("slabs") around 2011 — an early form of consumer crowd-equity that later fed a large and fragmented retail register (The Courier, Ballarat). Products were contract-brewed. **Phase 2 — Vertical-integration and China ambition (2016–2020).** Post-IPO, Broo acquired the Mildura Brewery (an operating brewpub on the site of the former Astor Theatre in Mildura) for about A$1 million so it could brew its own brands, operated the Sorrento Brewhouse on the Mornington Peninsula, purchased 15 hectares of industrial land in the Ballarat West Employment Zone (BWEZ) to build a A$95–100 million brewery and entertainment complex, and contracted with Jinxing Beer Group (brewing) and Beijing Jihua Information Consultants (distribution) for China (Business News Australia; Drinks Trade; Brews News). Domestically, packaged product was sold into independent liquor stores under a distribution arrangement with ALM (Drinks Trade, 2019). **Phase 3 — Retrenchment to an asset-light brand shell (2021–present).** In June 2021 the company stated it would focus on outsourced production through CUB (Carlton & United Breweries) and allocate funds to marketing and distribution rather than building its own brewery (Brews News). Following the 2022 board change, hospitality and brewing subsidiaries were deconsolidated and liquidated, leaving a parent company with no revenue, intangible assets written down to nil, and residual trademarks. ### Revenue model and value-chain position | Dimension | Characterisation | |---|---| | Revenue model | Product sales (packaged beer, draught) plus venue food and beverage (hospitality); planned but never-realised royalty/distribution income from China | | Product vs service vs licensing mix | Product-dominant; hospitality services until May 2022; licensing (China royalties) contracted but zero realised | | Value-chain position | Brand owner and marketer; intermittent own brewing (Mildura, Sorrento) 2017–2022; otherwise contract brewing (CUB in Australia; Jinxing in China) | | Customer types | Independent liquor retailers (via ALM wholesale), on-premise venues, direct consumers at owned venues | | End-markets | Australian mainstream/premium-mainstream beer; Chinese imported/international-brand beer (contracted, not realised) | | Current status (FY2023) | No revenue; no operating subsidiaries; brand trademarks impaired to nil |

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2009
Melbourne, Australia
Brisbane

Brisbane Broncos Limited

Premium
Information Technology

Brisbane Broncos Limited is the only publicly listed club in Australia's National Rugby League (NRL) and one of the country's most commercially powerful sporting franchises. It owns and operates the Brisbane Broncos NRL and NRLW teams, monetising a fan base the club describes as more than one million supporters through memberships, ticketing and corporate hospitality at the 52,000-seat Suncorp Stadium, sponsorship, merchandise, community programs and a contracted central distribution from the Australian Rugby League Commission (ARLC) secured to November 2034. The business is debt-free, carries AUD 36.0M of cash (31 December 2025), and has compounded gross revenue from AUD 51.0M (FY2021) to AUD 98.3M (FY2025). Control rests with News Corp (68.87%) and BGM Projects (~22%), leaving a free float under 10%. The 2025 double premiership (NRL and NRLW) produced record profits; a failed 2026 title defence now tests how much of that uplift is structural rather than cyclical. --- **Company's own description.** The FY2025 Annual Report states that the Group's principal activity is the management and operation of the Brisbane Broncos Rugby League Football teams, with no significant change in the nature of activities during the year. The Group reports a single operating segment and states that it operates in Australia only. Management characterises the Broncos as one of the largest and most popular sporting brands in the country, with a strong balance sheet, a stable commercial business and a disciplined focus on operating profit. **Independent characterisation.** BBL is best understood as a licensed content producer and live-entertainment operator inside a centrally governed league. Unlike US franchise models, the Broncos do not own broadcast rights; the NRL/ARLC sells media rights centrally and redistributes a fixed grant to each club. BBL's economic engine therefore has two layers: 1. **A quasi-annuity layer** — ARLC grants (AUD 22.2M in FY2025, 22.6% of gross revenue) under a Club Licence Agreement and Club Funding Agreement in place until 1 November 2034, plus government cost-recovery funding for community programs (AUD 10.5M, 10.6%), and interest on net cash (AUD 1.3M). 2. **A performance-geared layer** — memberships, ticketing, corporate hospitality and game-day revenue (AUD 31.3M, 31.8%), sponsorship (AUD 18.1M, 18.4%), merchandise (AUD 9.7M, 9.9%), royalties, prize money and finals incentives. This layer is highly sensitive to on-field success, home-game count and crowd size. **Value-chain position.** BBL sits mid-chain: upstream it depends on the ARLC (competition rules, salary cap, central funding, draw), Stadiums Queensland (Suncorp Stadium hire under a short-term/low-value lease arrangement), and kit/merchandise suppliers (ASICS as apparel partner). Downstream it sells directly to members, ticket buyers and corporate hospitality clients, and indirectly to sponsors who purchase audience reach (the club reported a FY2025 live television audience above 31.9M viewers, up 42% year on year, and the highest regular-season viewership of any NRL club). **Customer types.** (i) Individual fans/members (60,541 members in 2025; 70,886 as at 30 June 2026); (ii) corporate hospitality buyers; (iii) sponsors across a six-tier hierarchy (Major, Premier, Platinum, Associate, Support, Official); (iv) Federal and Queensland governments (as funders of Indigenous education programs); (v) the ARLC/NRL (as distributor and licensor); (vi) merchandise consumers (online and retail). **End-markets.** Live sport and entertainment in South-East Queensland; national sports sponsorship and media audiences; licensed sports merchandise; Indigenous education and social-impact programs in Southern Queensland and Northern New South Wales; junior/pathway rugby league development.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1987
Brisbane, Australia
Brightstar

Brightstar Resources Limited

Premium
Information Technology

Brightstar Resources is a Perth-headquartered, Western Australia-focused gold developer and emerging producer executing a "hub-and-spoke" consolidation strategy across three goldfields: Laverton, Menzies (together the "Goldfields Project/Hub") and Sandstone. Since 2023 it has transformed from a sub-1Moz explorer with an idle processing plant into a fully funded developer through four scrip-based consolidations (Kingwest, Linden Gold Alliance, Alto Metals, Aurumin) plus the Montague East purchase, lifting group Mineral Resources roughly tenfold to 5.2Moz. In May 2026 the Board took a Final Investment Decision on the Goldfields Project — a new 1.5Mtpa CIL plant at Laverton targeting first gold in the June quarter of 2027 and average production of more than 75koz per annum over an initial six-year life — financed by a A$193m equity raise and a US$120m Nordic bond. Its longer-term "TARGET200" aspiration (+200koz p.a.) depends on Sandstone, where a PFS and maiden Ore Reserve are due in the December 2026 quarter. --- ### Company's own description The FY2026 Annual Report defines the Group's principal activities as "mineral exploration, mining operations, mine development and the sale of gold in Western Australia." It describes Brightstar as the 100% owner of the Goldfields Project (Laverton and Menzies) and the Sandstone Project, and articulates the ambition of becoming a "significant Western Australian mid-tier gold producer." ASX boilerplate describes the company as an emerging gold producer and developer pursuing sequential development of the Goldfields Project followed by Sandstone. ### Independent characterisation Brightstar is best characterised as a single-commodity, single-jurisdiction, pre-steady-state gold developer whose current revenue is transitional. Its revenue history to date (FY2025–FY2026) was generated almost entirely under an Ore Purchase Agreement (OPA) with Genesis Minerals Limited, under which Brightstar mined underground ore at Second Fortune and Fish (and a small parcel from Lord Byron), hauled it to Genesis' Laverton mill, and was paid on recovered gold. Across the OPA, ~400kt @ 2.2g/t Au was processed for ~24koz recovered and A$138m of gross sales proceeds. That model ended during FY2026; mining was paused at Fish (March 2026) and Second Fortune placed on care and maintenance (August 2026), with ore stockpiled for Brightstar's own plant. From mid-2027 the business model shifts to a conventional owner-operated, vertically integrated gold mining model: Brightstar mines (owner-operator underground; open pits at Lord Byron, Cork Tree Well and Lady Shenton), hauls ore to its own 1.5Mtpa carbon-in-leach (CIL) plant at Laverton, and sells doré/refined gold. There is no product, subscription or licensing mix — revenue will be 100% gold sales, priced at spot (with a put-option floor over 60koz). ### Revenue model, value-chain position, customers and end-markets | Dimension | Characterisation | |---|---| | Revenue model | 100% commodity sales (gold). FY2025–FY2026: ore sales under OPA (revenue recognised on recovered gold, net of OPA processing terms). From FY2027/28: refined gold sales from own processing plant | | Product vs service mix | 100% product (gold); no service, subscription or licensing revenue | | Value-chain position | Upstream: exploration → resource definition → mine development → mining → processing (from 2027). No refining or downstream activity | | Customer types | FY2025–FY2026: Genesis Minerals (OPA counterparty, effectively a single customer). Post-2027: gold refiner/offtaker (not publicly disclosed) | | End-markets | Global gold market (investment, central bank, jewellery, industrial demand) via spot pricing in A$ | | Hedging | Purchased put options over 60koz at A$5,809/oz (US$4,000/oz), settling across FY2028–FY2029; full upside retained | | Operating model | Owner-operator underground mining (Fish, Second Fortune); EPC contract for plant (GR Engineering Services); contracted LNG-fired power (OCTA Group portfolio companies) | ### Analytical note on unit economics FY2026 revenue of A$64.1m on 14,419oz recovered implies ~A$4,448 per recovered ounce (derived). This is well below prevailing A$ spot prices (the DFS 2.0 cited a A$7,000/oz spot price at release in January 2026), consistent with OPA pricing that nets off third-party processing and the purchaser's margin. The step-change in realised value per ounce when Brightstar processes its own ore is the core economic logic of the Goldfields FID.

Revenue$0.0B
EmployeesN/A
Market CapN/A
Founded2002
Subiaco, Australia
Brandt

Brandt Consolidated Inc.

Premium
Information Technology

BRANDT is a second-generation, family-owned agricultural inputs group from central Illinois that combines two different businesses. The first is a regional, direct-to-grower agronomy retailer selling fertilizer, crop protection, seed and custom application through 18 outlets in the Corn Belt. The second is a proprietary specialty-formulations manufacturer selling foliar micronutrients, adjuvants, planter-box products, biologicals and turf nutrition through distributors in more than 80 countries. The retail arm provides scale, cash flow and a field laboratory; the specialty arm provides margin, brand and international growth. Under Rick Brandt, CEO since 1995, the group has grown mainly through acquisition (17 deals by 2022) and plant investment, with production in the US, Brazil and Spain. It competes with far larger listed groups, and its edge rests on formulation know-how, a recognisable brand, and the decision speed of a private owner. Its limits are scale, disclosure and exposure to the farm cycle. A precise latest headcount and a three-year trend are not publicly disclosed. --- **Company's own description.** BRANDT does not publish an annual report. Its standing press-release boilerplate describes it as a leading agricultural company serving growers around the globe, founded in 1953 to help Illinois farmers adopt new and profitable technologies, and now focused on products and services that give growers the best chance of a return. Recent releases describe it as a leading agriculture retailer and manufacturer of specialty agriculture products. **Independent characterisation.** BRANDT is a hybrid distributor-manufacturer. Its 2015 brochure described three complementary businesses, and the current structure is broadly as follows. **BRANDT Agronomic Services (retail):** Sells commodity and branded crop inputs plus application services to farmers in central Illinois. CropLife's profile for the 2023 data year gives the retail sales mix as fertilizer 48%, crop protection 26%, seed 20% and custom application 6%. **BRANDT Specialty Formulations (manufacturing):** Develops, formulates and markets proprietary specialty inputs under the BRANDT brand, sold business-to-business through ag retailers and distributors in the US. **BRANDT International:** Sells and, in Brazil and Spain, manufactures the specialty range outside the US and Canada. Products are available in 80–85 countries (company and trade press, 2025–26). **Adjacent lines:** Turf and ornamental nutrition, planter-box seed lubricants (BRANDT Planting Solutions, formerly Talc USA), and a dealer-support function serving other retailers. **Revenue model.** Revenue is overwhelmingly product sales. Service revenue is limited to custom application (about 6% of retail sales). No subscription or licensing revenue is disclosed. **Value chain position.** BRANDT sits downstream of basic fertilizer and active-ingredient producers. In retail it is the last link before the farm. In specialty it is a formulator and brand owner that sells through third-party retail. **Customers and end-markets.** Row-crop farmers in Illinois and Iowa (corn, soybeans); US ag retailers and distributors; specialty crop growers (fruit, nuts, vegetables, citrus) in California and Florida; organic growers (more than 50 OMRI-listed products per trade press); golf, sports turf and ornamental customers; and international distributors.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1953
Illinois, US
BPMMinerals

BPM Minerals Limited

Premium
Information Technology

BPM Minerals is a Perth-based, pre-revenue junior gold explorer. Over FY2026 it turned itself into a single-asset, gold-focused company centred on the ~630 km² Forelands Gold Project. Forelands lies about 150 km east of Kalgoorlie on the Yilgarn Craton–Albany Fraser Orogen margin. BPM holds the project under exclusive option agreements that it has not yet exercised. The company's geological thesis is that the Northern Foreland of the Albany Fraser Orogen is a geological analogue of the Tropicana Zone. Tropicana hosts the 7.89 Moz Tropicana deposit about 220 km to the north-east. BPM has drilled 70 RC holes for 10,606 m at Beachcomber. That work extended the high-grade Main Lode to more than 300 m of strike and about 250 m of vertical depth, and found three new lodes. In September 2026 the company began maiden drilling at the untested ~6 km Bonnie & Clyde gold-in-soil anomaly. BPM is debt-free, held A$6.6m in cash at 30 June 2026, and is targeting a maiden JORC resource at Beachcomber in 1H 2027. It has no resource, reserve or revenue today. --- ### Company's own description (paraphrased from FY2026 Annual Report) The Directors' Report describes BPM's principal activity as exploring and developing mineral projects, with an emphasis on Western Australian gold and nickel projects. The "nickel" wording is a legacy reference: by 30 June 2026 the company had no active nickel project in its reported portfolio. In the same report, management describes FY2026 as the year BPM completed its move to a single-asset, gold-focused explorer. It did so by selling Claw, relinquishing Santy and withdrawing from the Durack option, and it now concentrates on Forelands. The company's ASX boilerplate describes BPM as a Perth-based explorer of precious, base and critical minerals with WA projects, seeking landholdings in Tier-1 mining jurisdictions. ### Independent characterisation BPM is an early-stage, greenfield-to-brownfield gold exploration company. Its economic model is the classic junior explorer "discovery and monetisation" cycle: 1. **Acquire** prospective ground cheaply. BPM uses option structures that defer most consideration (shares, milestone performance rights, royalties) until it is satisfied with the geology. 2. **Add value** through systematic exploration: ultrafine-fraction (UFF) soil geochemistry, airborne magnetics, structural review and RC drilling. 3. **Fund** this almost entirely with equity placements, partly offset by asset sales (Claw to Capricorn Metals) and government co-funding (WA Exploration Incentive Scheme grants). 4. **Monetise** through one of three routes: (a) project sale or farm-out, (b) corporate takeover, or (c) development, most plausibly by toll-treating ore through one of several mills within about 200 km. ### Revenue model and mix | Revenue type | FY2025 (A$) | FY2026 (A$) | Comment | |---|---|---|---| | Product sales | 0 | 0 | No production | | Services / subscription / licensing | 0 | 0 | Not applicable | | Interest income | 66,025 | 99,108 | The only "revenue" line in the statutory accounts | | Asset-sale proceeds (cash, investing) | 0 | 600,000 | Claw sale; plus A$1,074,370 from selling Capricorn and Lodestar shares | ### Value-chain position, customers and end-markets BPM sits at the very start of the mining value chain (exploration and target generation). It has no customers in the conventional sense. Its "customers" are equity investors, and potential acquirers or toll-treatment partners such as mill owners in the Eastern Goldfields. The ultimate end-market for any future product is the global gold market (bullion, jewellery, central bank and investment demand). FY2026 management commentary attributes a supportive backdrop to an exceptionally strong gold price environment.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2020
West Perth, Australia
Botanix

Botanix Pharmaceuticals Limited

Premium
Information Technology

Botanix Pharmaceuticals is an ASX-listed, US-operated, single-product commercial dermatology company. Its sole marketed asset, Sofdra (sofpironium) topical gel 12.45%, is the first and only new chemical entity approved by the US FDA for primary axillary hyperhidrosis — an underserved condition the company sizes at roughly 10 million US patients, of whom about 3.7 million actively seek treatment. Botanix acquired global rights to sofpironium bromide from Brickell Biotech in 2022, secured FDA approval in June 2024, and launched nationally with a field sales force in February 2025. The commercial model pairs a dermatology-focused sales team with a proprietary closed-loop fulfilment platform (single specialty pharmacy, direct-to-patient shipping, prior-authorisation support) that bypasses wholesalers. FY26 net revenue reached A$33.8 million on A$152.8 million gross sales, but losses, a deeply discounted 2026 equity raise, a going-concern material uncertainty and a ~94% share-price decline since mid-2025 frame Botanix today as a high-growth, capital-constrained micro-cap. --- ### Company's own description (FY26 Annual Report, paraphrased) In its FY26 Directors' Report, Botanix characterises itself as a revenue-generating pharmaceutical company with an FDA-approved product, accelerating commercial traction, a proven fulfilment platform, and the infrastructure required for continued expansion. It positions Sofdra as a novel, safe and effective solution for primary axillary hyperhidrosis, citing its mechanism (blocking acetylcholine at the M3 receptor in the sweat gland), its rapid metabolism (designed to reduce systemic anticholinergic adverse events), and its proprietary applicator, which limits drug contact with the hands. It describes hyperhidrosis as the third-largest dermatologic condition in the US after acne and atopic dermatitis, and states that FY26 marked its transition from a development-stage biotechnology company to a revenue-generating commercial pharmaceutical business. ### What the company does Botanix in-licensed and now commercialises a single topical anticholinergic, Sofdra, in the United States. It does not manufacture: active pharmaceutical ingredient (API) is currently sourced from Kaken Pharmaceutical (Japan), finished goods are made at a contract manufacturing site in Canada, and dispensing occurs through a single specialty pharmacy network (identified in company footnotes as SendRx). Botanix's own value-add is commercial: sales force promotion to dermatologists, payer contracting, patient services, prior authorisation support, co-pay buy-down, refill management and marketing. ### Business and revenue model | Revenue stream | Mechanism | FY26 contribution (A$) | Source | |---|---|---|---| | Sofdra net product sales (US) | Product shipped to patients against prescriptions via the Botanix Fulfilment Platform; revenue recognised at delivery, net of rebates, chargebacks, co-pay support and government program deductions (gross-to-net) | 33,219,460 | FY26 AR, Note 3 | | Net royalties (Japan / South Korea) | Royalties received from Kaken Pharmaceutical on Ecclock (sofpironium bromide gel 5%) in Japan and via Kaken's South Korean sublicensee Dongwha Pharm; presented net of royalties Botanix must pay onward under the sofpironium asset purchase agreement (Botanix acts as agent) | 582,046 (1,293,437 received less 711,391 paid) | FY26 AR, Note 3 | | Services / subscription / licensing upfronts | None recognised in FY26 | 0 | FY26 AR, Note 3 | Mix for FY26: ~98.3% product, ~1.7% net royalty/licensing; 0% services or subscriptions. Revenue is entirely "goods transferred at a point in time". ### Value-chain position Botanix sits at the brand-owner/commercialiser layer of the specialty pharmaceutical value chain: IP owner and NDA holder, outsourcing chemistry (API), formulation and fill-finish to third parties, and outsourcing dispensing to a partner pharmacy while retaining control of the patient journey and data. Removing the wholesaler and consigning inventory directly to the pharmacy is presented by the company as a source of supply-chain cost savings and real-time data visibility (FY25 and FY26 Annual Reports). ### Customer types and end-markets | Stakeholder | Role | Notes | |---|---|---| | Patients with primary axillary hyperhidrosis (age 9+) | End user | ~10 million US patients; ~3.7 million actively seeking treatment (company estimate, adapted from 2019 Cowen analysis) | | Dermatologists, PAs and NPs | Prescribers | Unique prescribers grew from 1,075 (Q3 FY25 exit) to 2,316 (Q4 FY25 exit); later counts not disclosed | | Commercial payers / PBMs, Medicare Part D, Medicaid | Reimbursement | Payer contracts require confirmation of diagnosis and, for some, prior trial of aluminium chloride (FY25 AR) | | Specialty pharmacy (SendRx) | Dispensing partner | Single pharmacy network under the Botanix Fulfilment Platform | | Kaken Pharmaceutical / Dongwha Pharm | Licensee / sublicensee | Royalty-paying partners in Japan and South Korea; Kaken is also current API supplier | End-market: US prescription medical dermatology (hyperhidrosis segment); secondary exposure to Japanese and Korean hyperhidrosis markets via royalties. ### Independent characterisation Botanix is best understood as a single-asset US specialty pharma launch vehicle funded from the Australian equity market. Its operating metrics show genuine product-market traction — FY26 prescriptions shipped rose 527% to 105,794 and Q4 FY26 set a monthly record of 12,895 shipments — but the economics are dominated by a very low net-to-gross realisation (average gross-to-net "yield" of 22% in FY26, meaning roughly A$0.22 of net revenue per A$1 of gross sales), heavy promotional spend (A$52.0M product sales and marketing expense in FY26 versus A$33.8M of revenue), and dependence on a single API source in Japan. The investment case therefore rests on three levers: (i) improving gross-to-net toward the 30–40% management target, (ii) reducing cost of goods via the second API supplier (Piramal), and (iii) leveraging the fulfilment platform with additional in-licensed or acquired products. The balance-sheet position — A$36.6M cash against A$24.9M of secured Kreos debt at fair value and an auditor-noted material uncertainty on going concern — means execution must occur against a short funding runway.

Revenue$0.0B
EmployeesN/A
Market CapN/A
Founded1984
Melbourne, Australia
BossEnergy

Boss Energy Limited

Premium
Information Technology

Boss Energy is a mid-tier Australian uranium producer. Its business rests on two in-situ recovery (ISR) assets in tier-one jurisdictions. The 100%-owned Honeymoon operation in South Australia restarted in April 2024 and produced 1.407 Mlbs U3O8 in FY2026. A 30% joint-venture interest in Alta Mesa in South Texas is operated by enCore Energy. The company built its equity story on a 2021 Enhanced Feasibility Study (EFS) that targeted 2.45 Mlbs per annum. Boss withdrew that study in December 2025 after a review found poorer mineralisation continuity and leachability than assumed. In August 2026 it reset Honeymoon around a wide-spaced wellfield design: 13.8 Mlbs over nine years, with a peak of about 1.9 Mlbs a year from FY2030 to FY2033. Boss is deliberately under-contracted, holds 1.58 Mlbs of physical inventory, and has no debt. Its differentiation now rests on price leverage, balance-sheet strength, and a "one plant, three deposits" satellite growth strategy (Gould's Dam, Jasons). --- **What the company does.** Boss Energy explores for, develops, produces and sells uranium oxide concentrate (U3O8, "yellowcake"). It uses in-situ recovery: an acidic lixiviant is injected through wellfields into permeable sandstone-hosted ore, uranium-bearing solution is pumped to surface, and the uranium is recovered through ion exchange and precipitation. At Honeymoon, ion exchange uses NIMCIX columns. Five columns were operational by June 2026, alongside six producing wellfields (company "About Us" page, 2026). The final product is drummed U3O8. It is shipped to conversion facilities, mainly in Europe and North America, and sold to utilities and traders. **Company's own description (2026).** Boss describes itself as an Australian uranium producer with two projects in tier-one locations, and as a multi-mine producer with the 100%-owned Honeymoon Project in South Australia and a 30% interest in Alta Mesa in South Texas. It also states that the New Feasibility Study announced in August 2026 reset the Honeymoon life-of-mine plan around a wide-spaced wellfield design (paraphrased from bossenergy.com/about-us). **Business model.** **Product revenue, 100%:** All revenue comes from U3O8 sales. Boss has no service, subscription or licensing revenue. Interest income on cash (A$2.3M in FY2026) is reported in net financing, not revenue. **Sources of pounds sold:** In FY2026, revenue of A$151.1M came from 1,400 klbs sold: - 1,000 klbs of produced uranium generated revenue of A$109.1M. - 400 klbs of purchased inventory generated A$41.9M, including the A$15.5M repayment of the uranium loan to enCore. This purchased stock came from 1.25 Mlbs bought in March 2021 at US$30.15/lb. - In FY2025, all A$75.6M of revenue came from purchased inventory (650 klbs at an average US$75/lb), and all produced pounds went to inventory. **Contracting strategy:** Boss is "strategically under-contracted" (FY2026 Results). It favours spot and market-related exposure over fixed-price long-term contracts. FY2026 average realised price was A$111/lb (US$74.4/lb); the June 2026 quarter realised A$107/lb. **Inventory as a strategic asset:** Boss held 1.581 Mlbs at 30 June 2026, booked at A$116.3M. Spot-price value was about A$195M at UxC spot of US$84.85/lb and AUD:USD 0.6869. **Value-chain position.** Boss is a pure upstream mining company covering exploration, ISR extraction and processing to U3O8. It does not participate in conversion, enrichment, fuel fabrication or power generation. **Customer types.** Customers are nuclear utilities in the US, Europe and Asia, plus uranium traders and intermediaries. Individual customer names are not publicly disclosed. World Nuclear News reported that the first Honeymoon shipment was bound for Europe. **End-markets.** The end market is civil nuclear power generation, both baseload and new-build. Emerging demand includes small modular reactors and power purchase agreements for data centres. The 7 October 2026 rally in Australian uranium equities was linked to a hyperscaler power deal with Constellation Energy (MarketScreener, 7 Oct 2026). **Independent characterisation.** Boss is now a single-plant, sub-2 Mlbs a year Australian ISR producer, with a passive 30% non-operated US position. It is transitioning from a growth-premium story (the 2.45 Mlbs EFS) to a show-me execution story. Its economic value is driven far more by the uranium price, the success of wide-spaced wellfields, and satellite permitting than by near-term volumes. The balance sheet (A$207M liquid, no debt) gives it time but not scale. Cost guidance for FY2027 (AISC A$83–92/lb) leaves only a thin margin at prevailing term and spot prices until the ramp-up in FY2028–FY2030.

Revenue$0.1B
Employees139
Market CapN/A
FoundedN/A
Subiaco, Australia
Boadicea

Boadicea Resources Ltd

Premium
Information Technology

| Field | Supplied value | Verified / current value | Status | |---|---|---|---| | Legal name | Boadicea Resources Ltd | BOA Resources Limited (name change approved at the 29 Nov 2024 AGM) | Changed | | Country | Australia | Australia | Confirmed | | Exchange | Australian Securities Exchange | Australian Securities Exchange | Confirmed | | Ticker | BOA.AX | ASX: BOA | Confirmed | | ISIN | HK0023000190 | Incorrect for this issuer. The "HK" prefix denotes a Hong Kong security; an Australian issuer's ISIN carries an "AU" prefix. | Mismatch — flagged | | Website | http://www.boadicea.net.au | boaresources.com (used in all 2026 ASX releases) | Changed | The supplied identification details were checked against public records. The company is still listed on the ASX under ticker BOA, but two of the supplied details are out of date and one is incorrect. **Entity profiled:** BOA Resources Limited, ACN 149 582 687, an Australian public company listed on the ASX under code BOA. Website: boaresources.com. It is the same legal entity as Boadicea Resources Ltd, renamed. The ASX code BOA, the ACN and the listing date (11 October 2012) are continuous. ### Core facts | Item | Detail | Source | |---|---|---| | Legal name | BOA Resources Limited | ASX release, 25 Jun 2026 | | Former name | Boadicea Resources Ltd (name change approved at the 2024 AGM) | AGM results, 29 Nov 2024 | | ACN | 149 582 687 | ASX release, 25 Jun 2026 | | Incorporated | 2011 (Australia) | Stoxray / MarketBeat company profiles | | Incorporation jurisdiction | Australia (Corporations Act 2001 company) | ASX filings | | ASX listing (IPO) | 11 October 2012 | Market Index corporate details | | Headquarters (registered office) | Level 30, 35 Collins Street, Melbourne VIC 3000; registered-office change announced 6 Jul 2026 | Notice of General Meeting, 8 Sep 2026 | | Prior Melbourne address | Level 6, 99 William Street, Melbourne VIC 3000 | ASX release, 25 Jun 2026 | | Operational office | Ground Floor, 52 Kings Park Road, West Perth WA | ASX release, 21 Sep 2026 | | Exchange / ticker | ASX: BOA | — | | ISIN / CUSIP | no CUSIP (not US-listed) | — | | Fiscal year end | 30 June | Annual reports | | Share registry | Automic Group | Market Index | | Auditor | CNA Connect National Audit (most recent disclosure seen, 2024; FY2026 auditor not re-verified) | Market Index | | Employees | Not publicly disclosed. The disclosed key personnel are the Managing Director, an Exploration Manager (David Reid), a Senior Geologist (Nik Karakashov) and an outsourced Company Secretary (Lisa Wynne, CSB Corporate Services). | ASX releases, Jun–Sep 2026 | | Employee 3-year trend | Not publicly disclosed | — | | Share price | A$0.175 (close, 8 Oct 2026) | StockAnalysis.com | | Shares on issue (pre-transaction) | 290,622,246 (as stated in the 25 Jun 2026 capital-structure table). S&P data shows 276.33M at 30 Jun 2026; the discrepancy is unresolved. | ASX release, 25 Jun 2026; S&P via StockAnalysis | | Market capitalisation (current) | ≈A$50.9M (290.6M shares × A$0.175) — derived | Derived | | Pro-forma shares after the CVA transaction | 446,046,833 | ASX release, 25 Jun 2026 | | Pro-forma market cap at A$0.175 | ≈A$78.1M — derived | Derived | | Cash | A$2.433M at 30 Jun 2026 | June 2026 quarterly (Appendix 5B) | | Debt | Nil | FY2026 balance sheet (S&P) | | GICS sector | Materials | InvestSMART | BOA Resources is an ASX-listed junior explorer that, between November 2025 and October 2026, turned itself from a scattered critical-minerals explorer (nickel, lithium, rare earths and gold across Western Australia, Queensland and Tasmania) into a focused copper company in Western Australia's Murchison/Capricorn region. Its core asset is the Neds Creek Copper Project, roughly 1,378 km² of tenure in the Yerrida Basin. The project is anchored by the historic Thaduna and Green Dragon deposits, which BOA is acquiring from Sandfire Resources via Core Value Australia NL. These deposits sit on granted mining leases and carry a JORC 2012 resource of 5.3Mt at 2.3% Cu for 121kt contained copper. The Ricci Lee prospect, a geological analogue of Thaduna 2km away, returned high-grade results from BOA's maiden 2026 drilling campaign. BOA's investment case therefore rests on three things: resource growth toward economic scale, Sandfire's validation as an incoming roughly 6.2% shareholder, and copper's structural demand outlook. It remains pre-revenue, cash-constrained and dependent on equity funding. --- ### What the company does BOA Resources is a mineral exploration company. It does not mine, process or sell product, and it generates no operating revenue. Its "business" is to: - acquire prospective tenure; - add value through geological work and drilling, with the aim of defining JORC-compliant Mineral Resources; and - ultimately monetise those resources by developing them, selling them, joint-venturing them, or being acquired. BOA's 2026 disclosures describe the company as an Australian mineral exploration company focused primarily on copper assets in Western Australia (ShareCafe / ASX release, 22 Jul 2026). ### Company's own description (latest disclosures) In its June 2026 quarterly report, the company states that its immediate strategy is to grow its copper inventory toward economic scale. This is to be done through resource-definition drilling and by integrating the Thaduna and Green Dragon datasets into the broader Neds Creek exploration model (June 2026 Quarterly Activities Report, 24 Jul 2026). The 25 June 2026 announcement adds that the transaction is "a major step in BOA's strategy to build an extensive copper-focused portfolio in Western Australia's Murchison region." The FY2025 and earlier descriptions instead framed BOA as an explorer for "EV commodities" (nickel, copper, cobalt, lithium) with gold for stability. That framing is now superseded. ### Independent characterisation BOA is a project-generator-turned-consolidator. Its value-creation model in 2025–2026 has been to use its listed equity as acquisition currency to assemble a district-scale copper position: - 17.3M shares issued for 49% of Stanifer (Nov 2025); - 127.6M shares and 76.9M options proposed for 100% of CVA (Jun 2026); - 27.8M shares proposed to Sandfire. Alongside this, it has raised modest cash (A$3.75M placement at A$0.025) to fund drilling. BOA is a "resource-growth" equity: its valuation is driven by drill results, resource upgrades, copper price and corporate validation, not by earnings. ### Revenue model, value chain and customers | Dimension | Assessment | |---|---| | Revenue model | None. The only income is interest and other income (≈A$0.02M in FY2026; S&P data). | | Product / service / subscription / licensing mix | Not applicable — 0% of each | | Value-chain position | Upstream: greenfield/brownfield exploration and resource definition. No mining, processing, refining or trading. | | Customer types | None currently. Prospective counterparties for any future monetisation would be mid-tier and major copper producers, smelters, offtakers or acquirers. | | End-markets (indirect) | Copper. BOA's 25 Jun 2026 release attributes long-term demand to electrification, grid investment, electric vehicles, renewable energy and battery storage. Residual exposure remains to lithium (Cat Camp, Bald Hill East, Roy Hill-Tasmania), nickel/copper/cobalt (Fraser South) and gold (Boundary Fence; 10% Queensland interests). |

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2011
Melbourne, Australia
BoabMetals

Boab Metals Limited

Premium
Information Technology

Boab Metals is a Perth-based base and precious metals developer on the cusp of becoming a producer. Its single core asset, Sorby Hills near Kununurra in Western Australia's East Kimberley, is described by the company as Australia's largest undeveloped near-surface silver-lead deposit. Following a final investment decision in December 2025, Boab consolidated 100% ownership, secured more than A$350 million of debt and equity, bought Sandfire Resources' idle DeGrussa processing plant for relocation, and awarded a A$109 million EPC contract to GR Engineering Services. The September 2026 Project Delivery Plan extended mine life to 10.5 years and lifted base-case pre-tax NPV8 to A$1.06 billion. The investment proposition is a low-cost, shallow open-pit operation in which lead revenue is expected to cover operating costs, leaving silver as high-margin upside. Boab is thus primarily a leveraged silver-price instrument with execution risk concentrated in an 11-month construction window to first concentrate. --- ### Company's own description In its 2026 investor materials, Boab describes itself as an Australian resources company focused on exploring, developing and producing base and precious metals. It states that it is positioning to become a significant new silver and lead producer, capitalising on market fundamentals for both metals. It also notes a portfolio of exploration assets that could support resource growth and mine-life extension [Boab corporate presentation, September 2026]. Quarterly reports describe the company as advancing the fully funded, 100%-owned Sorby Hills Silver-Lead Project in the East Kimberley [Quarterly Activities Report, December 2025 quarter]. ### What the company does Boab is currently a developer: it explores, defines resources, permits, finances and is now building a mine. Once operational (target September quarter 2027), Sorby Hills will: - Mine ore by conventional shallow open-pit methods (excavator/haul truck) under a contractor model (RE:GROUP Australia binding Heads of Agreement, mining to start no later than 1 March 2027) [Kalkine/Grafa, Sept 2026]. - Process ore through the relocated and refurbished DeGrussa crushing/grinding/flotation plant to produce a single silver-bearing lead concentrate [DeGrussa completion release, 18 May 2026]. - Haul concentrate in sealed half-height containers by road train roughly 150–159 km to Wyndham Port, where Cambridge Gulf provides port access and stevedoring under a 10-year agreement, for shipment on Handy-class vessels to international smelters [Boab presentation Sept 2026; Project Delivery Plan, 29 Sep 2026]. ### Business and revenue model | Dimension | Characterisation | |---|---| | Revenue model (future) | 100% product sales — a lead-silver concentrate sold to traders/smelters under offtake (Trafigura) and tender/spot arrangements | | Product vs service vs subscription vs licensing mix | Product: 100% (prospective). No service, subscription or licensing revenue | | Current revenue | Interest income, management fees from the former Sorby Hills joint venture, and other income. A$0.17 million in FY2025 [S&P via StockAnalysis] | | Pricing mechanism | Concentrate priced on LME lead and LBMA/COMEX silver, less smelter treatment charges (TCs) and payability deductions. Spot lead-concentrate TCs are currently negative (smelters paying for silver-rich feed): Boab cites spot TCs of minus US$145/t versus +US$125/t assumed in the FEED Study [Boab presentation Sept 2026] | | Revenue mix (projected) | FEED basis (silver US$27.4/oz): lead ~A$1.8bn and silver ~A$0.7bn of life-of-mine revenue. At US$60/oz silver, silver exceeds 50% of revenue [Boab presentation Sept 2026]. Shaw and Partners estimated a ~60/40 silver/lead split at spot prices in February 2026 [Shaw and Partners equity report via OTC Markets, 25 Feb 2026] | | Cost model | Contractor mining, owner-operated processing, diesel-fired thermal power station (grid connection planned Q1 2028), six-year diesel supply contract with CGL Fuel (Cambridge Gulf) [Project Delivery Plan; June 2026 quarterly] | ### Value chain position Boab sits at the upstream mining and concentrating stage. It does not smelt or refine. Downstream, concentrate passes to traders (Trafigura) and smelters (predominantly Asian lead smelters, with India cited by Boab as a demand growth centre) who produce refined lead (mainly for lead-acid batteries) and recover silver (industrial uses, photovoltaics, electronics, investment). ### Customer types and end-markets | Customer type | Detail | |---|---| | Commodity traders | Trafigura Asia Trading Pte. Ltd. — binding offtake for 50% of concentrate (reduced from the original 75% base case because Boab used alternative financing rather than the Trafigura prepayment) [Dec 2024 quarterly; Project Delivery Plan, 29 Sep 2026] | | Smelters / traders (remaining 50%) | Expressions of Interest issued for the remaining 50% for the first two years of production; negotiations expected to start Q4 2026 [Project Delivery Plan] | | End-markets (indirect) | Lead: lead-acid batteries (automotive replacement and industrial). Silver: industrial (solar PV, electronics, EV electronics), jewellery/silverware and investment demand [Boab presentation, citing Silver Institute and ILZSG] | ### Independent characterisation Boab is best characterised as a pre-production, single-asset, silver-leveraged lead developer that has crossed the two hardest hurdles for a junior — permitting and full financing — and is now an execution story. Its economics are unusual: lead credits are projected to cover essentially all site costs (net C1 cost of US$2.80/oz of payable silver after lead credits in the base case), so the silver price drives free cash flow sensitivity [Project Delivery Plan, 29 Sep 2026]. Corporate strategy has been to minimise capital intensity by buying second-hand infrastructure (DeGrussa plant), using existing regional infrastructure (sealed roads, Wyndham Port) and contracting out mining. Its key vulnerabilities are single-asset concentration, construction and ramp-up risk in a remote location subject to a wet season, and leverage once the A$236 million debt facility is drawn.

Revenue$0.0B
EmployeesN/A
Market CapN/A
Founded2003
West Perth, Australia
BNKBanking

BNK Banking Corporation Limited

Premium
Information Technology

BNK Banking Corporation is one of Australia's smallest listed ADIs. It is a branchless, broker-distributed bank with about A$1.28 billion of total assets, A$994 million of on-balance-sheet lending and A$1.06 billion of deposits at 30 June 2026. It also services about A$1.0 billion of third-party-funded managed loans. Its roots are a 1982 Western Australian credit union. A short-lived experiment as a bank-plus-mortgage-aggregator ended with the A$152 million sale of Finsure to MA Financial in February 2022, and most of the proceeds were returned to shareholders. Since mid-2022 management has repositioned the balance sheet away from low-margin prime residential mortgages toward commercial lending (25% of the book), specialist residential lending through a Goldman Sachs-funded warehouse, and senior secured credit (4%). Net interest margin has risen from 1.06% (FY24) to 1.96% (FY26). Profitability remains marginal, and the shares trade at about 0.25x net tangible assets. The strategic test for FY27 is a core-banking replacement and a stable leadership team. --- ### Company's own description In its FY26 annual report, BNK describes its principal activities as the provision of retail and commercial banking and mortgage management. Its standard ASX boilerplate (FY26 results release, 27 Aug 2026) describes a branchless bank offering a focused range of deposit and lending products through a national broker network, key aggregator partnerships and expanding digital channels, under two brands, Goldfields Money and Better Choice Home Loans. The FY26 Chairman's letter frames the strategic aim as being the bank for "Enterprising Australians". That positioning was first articulated under former managing director Simon Lyons. It targets self-employed borrowers, small-business owners, trusts, SMSFs and others with complex finances whom major banks underserve (Mortgage Business / Broker Daily). The segment note (FY26 Annual Report, Note 2.1) gives the operating model in detail: **Lending:** Loans are distributed through the Better Choice business, through online applications and through the accredited mortgage broker network. They may be funded by deposits, by securitisation vehicles or by third-party funders. **Warehouses:** Existing securitised funding warehouses are with Goldman Sachs (A$500m) and Bendigo and Adelaide Bank (A$121m). **Broker economics:** Introducer brokers receive upfront and trail commissions. Better Choice Wholesale earns and pays commissions on legacy white-label loan books. **Deposits:** Deposits are raised under the Goldfields Money / BNK brands directly and through third-party deposit brokers. **Income:** The bank earns net interest income plus service fees from retail and small-business customers. ### Independent characterisation BNK operates as a spread lender with an originate-to-distribute overlay. It has four economic engines: 1. **On-balance-sheet net interest income (about 90% of FY26 total net income).** BNK funds residential, commercial and senior secured loans mainly with retail deposits. These are at-call (A$522m) and term (A$527m), raised largely through online rate-comparison and deposit-broker channels. A new negotiable certificate of deposit (NCD) programme (A$10.9m outstanding) and a Bendigo-funded prime warehouse (Bullion Warehouse No.1 Trust, A$70.4m) add to funding, as do A$24m of Tier 2 subordinated notes, of which A$8.75m was redeemed after year-end. NII was A$24.0m in FY26. 2. **Origination and servicing fees from third-party warehouses.** BNK originates, underwrites and services "Ultimate"-branded specialist residential loans for a Goldman Sachs warehouse (A$434.4m at 30 Jun 2026) and the Robusta 2024-1 RMBS trust. Total Goldman programme originations were A$598.4m. Those loans sit off balance sheet. BNK earns servicing, origination and management fees plus a profit share after term-out (FY26 Annual Report, OFR). 3. **Periodic portfolio sale gains.** In FY25 BNK monetised loans through a whole-loan sale from the Bullion Trust to Bendigo Bank and the Robusta securitisation of Goldman warehouse assets. These contributed A$3.2m of "other" income (FY26 Annual Report, Note 2.3). Management says such transactions will recur, but their timing is lumpy (FY26 results release). 4. **Run-off trail book (legacy wholesale).** A reducing pool of third-party-funded loans generates trail commissions. Under AASB 15 a contract asset is recognised (A$4.5m) along with a broker trail payable (A$1.4m). Its unwinding is a recurring non-cash drag that management adds back in "underlying" earnings (A$2.3m pre-tax in FY26). **Revenue model mix (FY26, derived from Note 2.3):** gross interest income A$67.4m; commission income A$3.0m; other income A$4.9m, made up of service fees and residual income A$3.2m, lending fees A$0.8m and transaction fees A$0.9m. There is no product sale, subscription or licensing revenue. On a net basis, 89.6% of total net income came from NII, 18.3% from other income, and net commissions subtracted 7.9%. **Value chain position.** BNK is a balance-sheet provider and manufacturer of loan and deposit products. It outsources distribution to mortgage brokers and aggregators (including Finsure, its former subsidiary, now owned by MA Financial) and to deposit brokers and comparison sites. It insources credit assessment, servicing and treasury, and buys core banking technology from vendors. Since the Finsure sale it has no proprietary distribution of scale. **Customer types and end-markets.** Customers are retail depositors, owner-occupier and investor residential borrowers (prime and near-prime / specialist), SME and commercial property borrowers, bank-guarantee clients (through a partnership with Assuro), and wholesale counterparties in senior secured lending programmes. All end-markets are in Australia.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1982
Perth, Australia
Bluechiip

Bluechiip Limited

Premium
Information Technology

Bluechiip was a Melbourne-based developer of wireless tracking technology for biological samples stored in extreme environments. Its core intellectual property was a MEMS (micro-electro-mechanical systems) resonator tag that contains no electronics. A reader excites the tag and identifies it from its mechanical resonance signature, and it also reads the sample temperature. The company claimed this works from liquid-nitrogen temperatures (about -196°C) to +200°C, through frost, and after autoclaving, gamma sterilisation and centrifugation, where labels, barcodes and conventional RFID struggle. From 2011 to about 2020 Bluechiip operated mainly as an R&D and OEM-licensing company (notably with Labcon North America). From late 2021 it pivoted to direct sales of a branded "Advanced Sample Management Solution" (tagged cryovials, readers and Stream software) to biobanks, pharma and cell-and-gene-therapy labs. Revenue never exceeded about $1m a year. Repeated dilutive raises could not fund the commercial ramp, and the company entered administration in March 2025 and liquidation in mid-2025. --- **What the company did.** The FY2024 Appendix 4E describes the principal activity as developing and commercialising a wireless tracking solution for healthcare and life science, security, defence and manufacturing. The company positioned this as a generational replacement for handwritten and pre-printed labels, linear and 2D barcodes, and chip-based RFID. In practice, nearly all commercial activity from FY2019 onward was in life sciences: cryogenic storage of cells, tissues, blood products, embryos and gametes, and cell-and-gene-therapy (CGT) materials. **Technology.** Each Bluechiip tag is a miniature mechanical chip. Because it has no integrated circuit, it tolerates temperature extremes and sterilisation processes that damage silicon RFID. Corporate boilerplate in ASX releases states that the system does not need line of sight, can read through frost, and senses the temperature of each tagged item. That last capability was the key differentiator: an ID plus a per-sample temperature record in cryogenic storage. Management repeatedly described this in releases as the only system offering ID with sample temperature in cryogenic environments. **Business model and revenue model.** The model evolved through three phases: 1. **R&D / co-development (2003 to about 2017).** Funded largely by equity and the Australian R&D Tax Incentive (RDTI), with little or no ordinary revenue. The FY2011 report showed no revenue from ordinary activities. 2. **OEM supply and licensing (about 2017 to 2021).** The anchor was a three-year supply agreement with Labcon North America that management valued at more than US$11.6m (about A$15.9m) when FY2019 results were reported. FY2019 revenue reached a record $1.025m. The Labcon relationship later ended in a settlement involving product returns and a cash payment. 3. **Direct-to-market branded solutions (December quarter 2021 to 2024).** Bluechiip launched its own branded Advanced Sample Management Solution into the global biobanking market. In 2022 it registered its own range of storage products, including cryovials. Revenue in this phase came from (a) one-off product sales (readers, tagged consumables, racks and boxes), (b) recurring consumables and annual Stream software licences, (c) engineering services for OEM partners, and (d) licence fees (Fujifilm Irvine Scientific 2021; BioLife Solutions 2024). **Revenue mix (FY2024 Appendix 4E, Note 3):** In FY2024, product and software made up about 95% of revenue. Engineering services collapsed because OEM activity fell. Software licences were not separately broken out from product sales, so the true "subscription" share cannot be isolated. The June 2023 quarterly report noted recurring revenue (consumables, annual Stream licences and additional readers) of about $75k in that quarter, roughly triple the December 2022 quarter. **Value chain position.** Bluechiip designed the MEMS tag and reader electronics and outsourced most semiconductor fabrication. A 2023 Supply Chain Resilience Initiative (SCRI) grant was intended to build an in-house micro-electronics fabrication line, but the project was terminated in June 2024. Bluechiip then integrated tags into consumables (cryovials, blood bags or cassettes, CGT bags) and sold readers and software. It sat between component suppliers (MEMS foundries, plastics moulders) and end users (biobanks, pharma, CGT manufacturers, IVF clinics), and also sold to OEM partners who embedded the tag in their own consumables (Labcon, Fujifilm Irvine Scientific, BioLife Solutions). **Customer types and end-markets.** Biobanks and biorepositories; global pharmaceutical companies (management disclosed orders from three "top-20" pharma companies by November 2023); cell and gene therapy developers and manufacturers; assisted reproductive technology (IVF) through the Fujifilm Irvine Scientific programme; and research institutes and hospital labs. By June 2023, 14 end-users had ordered across 26 laboratories (FY2022: 10 labs). The December 2024 quarterly report stated sales to 38 laboratories across 18 customers. **Independent characterisation.** Bluechiip was a sub-scale, pre-profit deep-tech hardware company with a credible niche technology and a structurally hard go-to-market. Its products required customers to change validated cold-chain workflows and switch consumables, which brought long sales cycles (as management itself acknowledged in the FY2024 commentary), high cost-to-serve, and heavy working-capital needs. At 30 June 2024 inventory was $3.30m, about 6.8 times FY2024 revenue. The company never reached revenue scale to cover a cost base of about $6.7m a year, and it relied on equity raised at progressively lower prices, RDTI refunds and expensive R&D advance loans (16% p.a. in FY2024).

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2003
Scoresby, Australia
BLUEENERGY

BLUE ENERGY LIMITED

Premium
Information Technology

Blue Energy is a Brisbane-based, micro-capitalisation natural gas explorer and appraiser whose value is concentrated in 100%-owned and operated coal seam gas (CSG) acreage in Queensland's North Bowen Basin (ATP 814) and the Surat Basin (ATP 854), with frontier farm-in acreage in the Northern Territory's Greater McArthur/Wiso/Birrindudu region. Its flagship is the Sapphire project, now held under 20-year Production Licence PL 1034 (granted September 2025), carrying NSAI-certified 91 PJ of 2P and 287 PJ of 3P reserves, located directly beside the producing Moranbah Gas Project, whose infrastructure Blue intends to use. Around it sit large contingent resources in newly granted Potential Commercial Areas, positioning the company as a potential new supplier into a tightening east coast gas market. Its constraints are equally clear: no revenue, roughly A$4m of cash, a going-concern material uncertainty, a share count that has risen 63% in a year, and commercial offtake agreements that remain non-binding. --- **What the company does.** Blue Energy explores for, appraises and seeks to commercialise natural gas, predominantly unconventional coal seam gas held in Permian-age coal measures. It operates 100% of its Queensland tenements and is the Operator of its Northern Territory permits, where it earns equity through a farm-in. Being operator everywhere means Blue controls work programs, capital and the regulatory interface with the Queensland and NT governments (FY2025 Annual Report, Principal Activities). **Company's own description (FY2025 Annual Report, paraphrased).** The company describes itself as an energy company undertaking exploration, evaluation and development of conventional and unconventional oil and gas resources, conducted in a single geographic segment (Australia, principally Queensland and the Northern Territory), with no change in principal activities from the prior year. **Business model.** Blue follows the classic junior E&P "appraise-to-monetise" model: 1. Acquire large acreage positions at low cost. 2. Drill appraisal and pilot wells to convert contingent resources (1C/2C/3C) into certified reserves (1P/2P/3P) via independent certifier Netherland, Sewell & Associates Inc. (NSAI). 3. Upgrade tenure from exploration permits (ATPs) to Potential Commercial Areas (PCAs, 12-year holding tenure) and Production Licences (PLs). 4. Secure offtake (heads of agreement / MoUs with gas buyers) and infrastructure access. 5. Monetise either by developing gas (selling into the east coast market or to industrial users) or by farm-out/sale of equity. **Revenue model.** Currently zero operating revenue. Income consists solely of interest on cash deposits and fuel tax credits (FY2025 total income A$122k: interest A$90k, fuel tax credits A$32k). The prospective revenue model is gas sales (commodity product sales) under term gas sales agreements. Product vs service vs subscription vs licensing mix: 0/0/0/0 today; prospectively ~100% product (gas) sales. **Value chain position.** Upstream (exploration and appraisal). The company plans to avoid building its own gas processing facilities for Sapphire by processing gas at the adjacent Moranbah Gas Project operated by QPM Energy (QPME), connected via a proposed pipeline to the MGP Node 3 compressor station (ASX release 9 Sep 2025; FY2025 Annual Report). **Customer types (prospective).** (a) East coast gas retailers/utilities (AGL Energy and Origin Energy via non-binding heads of agreement, delivery at Wallumbilla); (b) industrial users (Queensland Pacific Metals' proposed Townsville nickel/cobalt refinery under a non-binding MoU); (c) QPM Energy for Sapphire pilot gas. **End markets.** The eastern Australian domestic gas market (Queensland, NSW, Victoria, SA, Tasmania) linked via the Wallumbilla hub, and indirectly the Gladstone LNG export complex, whose demand pulls on Surat/Bowen supply. **Independent characterisation.** Blue is best understood as a call option on east coast gas scarcity and on Queensland's regulatory willingness to approve new CSG development. Its asset base is technically substantial (multi-thousand-PJ contingent resource across ATP 814 and ATP 854) but commercially immature: the reserves are undeveloped, the offtake documents are non-binding, the pilot has produced only at test rates (peak ~140,000 standard cubic feet per day reported in FY2023), and the balance sheet cannot fund development. Its accounting equity (A$77.2m at 31 Dec 2025) is almost entirely capitalised exploration expenditure (A$73.1m), whereas the market values the whole company at roughly A$12m, a price-to-book of about 0.16x. This discount reflects funding and execution risk rather than geological doubt per se.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded1992
Queensland, Australia
Blackstone

Blackstone Minerals Limited

Premium
Information Technology

Blackstone Minerals is a Perth-headquartered, ASX-listed junior that has repositioned from battery-nickel development in Vietnam to copper-gold-silver porphyry development in the Philippines. Its flagship is the Mankayan Copper-Gold-Silver Project in Benguet Province, Northern Luzon. Mankayan hosts a JORC 2012 Mineral Resource of 793Mt at 0.65% CuEq, containing 2.8Mt copper, 9.7Moz gold and 20.4Moz silver. The company describes it as the fourth-largest undeveloped copper project in the Philippines. Blackstone controls the project through its affiliate, Crescent Mining & Development Corporation (CMDC). The legacy Ta Khoa Nickel Project in Vietnam is classified as held for sale. It is being farmed down to Vietnam's Xuan Loc Tho Co. Ltd. under a staged earn-in. The Gold Bridge gold project in British Columbia, Canada is a non-core holding. The company has no operating revenue and is funded by equity. It held A$13.8M cash at 30 June 2026 and is running a Pre-Feasibility Study due in FY2027. It is led by an Executive Chairman while a CEO search continues. --- ### What the company does Blackstone Minerals is a mineral exploration and project-development company. Its business is to acquire, delineate and de-risk mineral deposits through drilling, resource estimation, metallurgical testwork, engineering studies and permitting. The aim is to crystallise value either by developing a mine (usually with partners and project finance) or by selling or farming out assets. The company does not produce or sell minerals. Its cash inflows come from: - equity raisings; - option exercises; - interest income; - R&D tax incentive rebates; - occasional sales of listed investments. ### Company's own description The HYR H1 FY2026 describes the group's principal activity as exploration for copper and gold in the Philippines. It reports a single operating segment, "Philippines exploration projects", with Vietnam classified as held for sale. Earlier Annual Reports (AR FY2022–FY2024, branded "Mining Green. Looking Forward.") described a vertically integrated strategy. That strategy combined the Ta Khoa nickel-copper-PGE mine with a downstream Ta Khoa Refinery producing nickel-cobalt-manganese (NCM) precursor products for Asia's lithium-ion battery industry. ### Independent characterisation Blackstone is best understood as a single-asset, pre-feasibility-stage copper-gold developer. It carries a legacy nickel option and a small Canadian gold optionality. The company executed a "reverse-pivot": - It abandoned a capital-intensive nickel mine-to-precursor strategy after the 2023–2024 collapse in nickel prices, which was driven by Indonesian supply. - It used its listed vehicle to merge with IDM International, which owned Mankayan, in an all-scrip "merger of equals" completed in June 2025. The investment case now rests almost entirely on three things: 1. whether Mankayan's large, historically defined porphyry resource can be converted into a bankable underground (likely bulk-mining) project; 2. securing and maintaining a social licence in an Indigenous-peoples area of the Cordillera; 3. funding a multi-billion-dollar development, which is likely to need a strategic partner. ### Business, revenue and value-chain model | Dimension | Characterisation | |---|---| | Business model | Explorer / developer. Value is created through resource definition, studies, permitting and eventual development or sale | | Revenue model | No product, service, subscription or licensing revenue. Interest income was A$101,639 and other income A$37,367 in H1 FY2026 (HYR). An R&D rebate of A$1,081,780 was received in H1 FY2025 (HYR comparative) | | Value-chain position | Upstream: exploration and early-stage development. The intended future product is copper concentrate with gold and silver credits (Mankayan) | | Legacy value-chain ambition | Upstream nickel concentrate (Ta Khoa Nickel), mid-stream nickel/cobalt sulphate (Ta Khoa Refinery) and NCM811 pCAM (precursor cathode active material) | | Prospective customer types | Copper smelters and concentrate traders (Asia: Japan, China, Korea, Philippines' PASAR smelter), and gold refiners | | End-markets (ultimate) | Electrification and energy transition (copper), precious metals / store of value (gold, silver), and historically EV batteries (nickel) |

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2016
West Perth, Australia
EvionNL

Evion Group NL

Premium
Information Technology

Evion Group NL is a micro-capitalisation, Perth-headquartered critical-minerals developer that describes itself as a vertically integrated graphite company spanning three continents. Its cornerstone asset is the 100%-owned Maniry Graphite Project in southern Madagascar, which received Mining (Exploitation) Permits in July 2026 under Madagascar's new Mining Code and holds European Union "Strategic Project" status under the Critical Raw Materials Act framework, awarded in June 2025. Downstream, Evion owns 50% of Panthera Graphite Technologies, an expandable-graphite processing joint venture with India's Metachem Manufacturing near Pune, which delivered its first full year of commercial production to March 2026. A proposed Battery Anode Material plant in Germany remains at scoping-study stage. In 2026 the company diversified into fluorspar through an earn-in option over the historic Carp Fluorspar Project in Nevada. Evion remains pre-production at the mine level, loss-making at group level, and dependent on external equity funding. --- ### What the company does Evion Group NL is a resource developer rather than an operating miner. Its activities fall into four asset streams: 1. **Upstream graphite mining (development stage):** The Maniry Graphite Project in southern Madagascar, comprising the Razafy, Razafy Northwest and Haja deposits. Razafy and Razafy Northwest underpin the current development plan. A Definitive Feasibility Study (DFS) supports a conventional open-pit, contract-mined operation with staged concentrate output. 2. **Downstream expandable graphite processing (operating, equity-accounted):** A 50:50 joint venture, Panthera Graphite Technologies Pvt Ltd ("PGT"), with Metachem Manufacturing Company Pvt Ltd. Its plant is located in a Special Economic Zone near Pune, India. PGT converts natural flake graphite into expandable graphite. Expandable graphite is used in fire retardants, foils, gaskets and thermal management. 3. **Downstream battery anode material (concept/scoping stage):** A proposed Battery Anode Material (BAM) plant in Germany. It would process Maniry fine-flake concentrate into uncoated spheronised purified graphite (uSPG) for lithium-ion battery anode makers. 4. **Fluorspar exploration (early stage, option-based):** An exclusive option to earn 100% of the Carp Fluorspar Project in Lincoln County, Nevada, USA, from Globex Nevada Inc. (subsidiary of TSX-listed Globex Mining Enterprises). Fluorspar is classed as a critical mineral in the US, EU, Australia, Canada and Japan. Legacy BlackEarth-era assets included the Ianapera graphite project (about 5 km north of NextSource Materials' Molo project in Madagascar) and base-metal (Ni-Cu-PGE) prospects in Western Australia. Their current status in the portfolio is not prominently disclosed in recent materials, and they appear non-core. ### Business and revenue model | Revenue stream | Nature | Status | Accounting treatment | |---|---|---|---| | Expandable graphite sales (PGT JV) | Product sales, B2B, per-tonne pricing | Commercial since early 2025; first full year to 31 March 2026 | Equity-accounted (50% share); not consolidated into group revenue | | Maniry graphite concentrate | Product sales under offtake (planned) | Pre-development; permits granted July 2026; FID pending | N/A | | Battery anode material (Germany) | Product sales (planned) | Scoping study only | N/A | | Fluorspar (Carp) | Product sales (potential, long-dated) | Exploration | N/A | | Interest and other income | Treasury | Ongoing | Consolidated "other revenue" | The company has no subscription, licensing or services revenue. Its model is commodity product sales. Value capture is meant to come from moving down the value chain (concentrate, then expandable graphite or anode material) rather than selling concentrate alone. ### Value chain position Evion straddles the mine and processing segments of the natural-graphite value chain. Its strategic thesis rests on three claims: - It can offer a non-Chinese, EU- and US-aligned source of supply. - It already has a cash-generating processing foothold through PGT, which de-risks marketing before mine construction. - It can capture downstream margin in the future. ### Customer types and end-markets | End-market | Product | Evidence | |---|---|---| | Fire retardants / building materials | Expandable graphite | PGT sales; core product realisations above US$3,100/t (ASX, 4 June 2026) | | US graphite supply chain | Expandable graphite | A$1.5m sales agreement with a "major US graphite supply chain group" for 300t (announced 1 December 2025) | | Lithium-ion battery anode makers | uSPG / BAM (future) | Non-binding 15,000 tpa offtake MOU with Urbix Resources (US), 2022; BAM scoping study | | Refractories | Coarse flake concentrate | BlackEarth-era quality approval from a leading refractory producer (FY2020 reporting) | | Industrial / chemicals (fluorspar) | Acidspar / metspar (future) | Carp project; historic metspar production 1958–1971 | ### Company self-description vs independent characterisation **Company's own framing (paraphrased from FY2025/FY2026 reports and presentations):** Evion presents itself as a vertically integrated graphite developer with operations in Madagascar, India and Europe. Since 2026 it has added US fluorspar and calls itself a "critical minerals" group. It emphasises EU Strategic Project recognition, a 21-year Maniry mine life and the cash-generative Indian JV. **Independent characterisation:** Evion is a sub-A$20m explorer/developer whose only operating economics sit inside a 50%-owned, equity-accounted Indian processing JV. The group consolidated P&L shows no product revenue and recurring net losses of A$2.7–3.7m per year. The flagship mine needs initial capex of about US$80m, many times the company's market value, so financing (EU/EIB, offtake prepayments, strategic equity) is the central value driver. The 2026 fluorspar option adds optionality but also dilutes management focus and cash.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2016
West Perth, Australia
BLACK

BLACK ROCK MINING LIMITED

Premium
Information Technology

Black Rock Mining is a pre-revenue, single-asset critical-minerals developer. Its only material asset is an 84% stake in the Mahenge Graphite Project in south-eastern Tanzania. Mahenge hosts a JORC Mineral Resource of 213 Mt at 7.8% total graphitic carbon (TGC) and an Ore Reserve of 70.5 Mt at 8.5% TGC, which the company describes as the world's second-largest graphite Ore Reserve. The project holds: - a granted 26-year Special Mining Licence; - a Framework Agreement with the Tanzanian Government; - a US$204m syndicated debt package from DBSA, IDC and CRDB; - long-term fines offtake and a strategic equity relationship with POSCO; - binding large-flake offtakes with two Chinese buyers. Black Rock's proposition is a low-cost, hydro-powered, modular "crawl, walk, run" upstream concentrate operation that can produce both battery-anode feed and premium large flake outside China. The only missing piece is about US$100–111m of project equity. With a market capitalisation of roughly A$25–28m against a published attributable NPV of US$730m, the stock is effectively a binary financing option. The binding near-term date is the 30 November 2026 debt-facility deadline. --- **What the company does.** Black Rock Mining is a mineral development company. Its principal and essentially only activity is advancing the Mahenge Graphite Project toward a Final Investment Decision (FID), construction and production of natural flake graphite concentrate. The company has never produced or sold graphite. Its income consists of interest on cash balances and occasional minor rental income: total income was A$15,522 in H1 FY26 versus A$39,421 in H1 FY25 (H1 FY26 Report, Note 2). Data vendors record "revenue" of about A$4.1k in FY2024 and A$12.5k in FY2025 (MarketScreener). **Company's own description.** On its website (Sep 2026) the company presents itself as a "Premium Graphite Developer" with the tagline "Naturally Better Graphite". It describes its purpose as developing the world-class Mahenge Graphite Project in Tanzania, a large-scale resource able to support decades of production and meet growing global demand for natural graphite. The FY2025 Sustainability Report positions Mahenge as a critical supplier of low-carbon battery materials, contributing to decarbonisation of the transport and electricity sectors. **Intended business model (post-FID).** - Black Rock plans to be a pure upstream miner and concentrator, not a vertically integrated anode producer. - Contract open-pit mining (Taifa Mining and Civils) will feed on-site crushing, milling and flotation, with dry-stack tailings. - Concentrate will be bagged, containerised and trucked to Dar es Salaam for export. Rail via the TAZARA line from Ifakara is an option for later modules. - The company deliberately avoids downstream spheronisation and purification. Breakaway (Jul 2026) characterises this as cutting out significant execution and technology risk. **Revenue model (prospective).** Revenue will be 100% product sales of graphite concentrate under offtake contracts. There is no service, subscription or licensing income. The product mix is split between: 1. **Fines (-100 mesh)** for lithium-ion battery anode precursor (spherical purified graphite, SPG). 100% of Module 1 and Module 2 fines are contracted to POSCO. 2. **Large flake (+100 mesh and coarser)** for refractories, expandable graphite, foils, friction materials, thermal management and other industrial uses. Contracted in part to Muhui International Trade (Dalian) and Qingdao Yujinxi New Material, with a POSCO marketing agreement for large flake sold outside China. Metallurgical testwork indicates about 59% coarse flake (+80 mesh) and 41% -80 mesh, at concentrate grades of 95–99% TGC (Breakaway, citing company data). The company's pricing assumes grade premiums of 10% for fines (96% TGC) and 25% for large flake (97.5% TGC) over standard 94–95% TGC benchmarks (company website cost-curve note). **Value chain position.** Mahenge sits at stage 1 (mining and concentration) of the natural graphite chain. The next stages are SPG / purification, anode active material, battery cell, and EV / ESS. On the industrial side the chain runs through refractories and expandable-graphite producers. POSCO Future M, an associate of offtaker POSCO International, is building an SPG plant in Pohang (Breakaway cites US$277m and 37 ktpa) to support its Sejong anode plant (70 ktpa per the H1 FY26 Report). That gives Mahenge fines a captive downstream home. **Customer types and end-markets.** Breakaway (Jul 2026) states that about 85% of Module 1 offtake plus Module 2 fines are covered under these agreements. The company's website states ">95% contracted" for products. These two figures conflict. The difference likely reflects whether buyer options and the POSCO MoU are counted. **Independent characterisation.** Black Rock is a shovel-ready but under-capitalised developer. Its technical and permitting de-risking is unusually advanced for a company of its size: an SML, Framework Agreement, resettlement completed, debt documentation signed, offtake, a mining contractor, power agreements and early works. Its equity-market position, however, is that of a micro-cap explorer. The business model's success depends almost entirely on one transaction: a project-level equity sell-down or strategic equity injection of about US$100–111m, due before 30 November 2026. Until that happens, the operating "business" is a cost centre of about A$1.5–2.5m per quarter, funded by dilutive placements.

RevenueN/A
EmployeesN/A
Market Cap$0.0B
Founded2000
West Perth, Australia
Black

Black Cat Syndicate Limited

Premium
Information Technology

Black Cat Syndicate is a Western Australian gold producer that has moved, within roughly 21 months, from explorer-developer to a two-hub producer. Its first gold was poured at Paulsens in December 2024. FY2026 output was 90,833oz, of which 66,296oz was wholly owned production. It runs two operating hubs. The first is the high-grade underground Paulsens operation in the Pilbara, with a 450ktpa mill. The second is the Kal East operation near Kalgoorlie, fed by the Fingals open pit and the Majestic underground mine through the 1.2Mtpa Lakewood mill, which it bought from Westgold. It also holds the care-and-maintenance Coyote operation in the West Tanami and the Mt Clement antimony-polymetallic project. The company is unhedged and carries no debt, with A$105.3M in cash and liquid assets at June 2026. FY26 statutory revenue was A$374.3M and NPAT A$86.5M. The equity story is high gold-price leverage combined with an execution-heavy ramp-up. That story has been tested by a sharp management reset in September 2026 and by cost guidance that came in below market expectations. --- ### What the company does Black Cat is a single-commodity (gold) mining company with a nascent critical-minerals option at Mt Clement (antimony, silver, lead, copper, gold). Its business has five parts: **Exploration and resource definition:** Drilling defines and extends Mineral Resources across three districts. The JORC 2012 gold Resource is 29.1Mt @ 2.7g/t Au for 2,524koz [Q4-FY26, Appendix 1]. **Mine development and mining:** Underground mining runs at Paulsens and Majestic, and open-pit mining at Fingals. Myhree/Boundary open-pit mining concluded in the December 2025 quarter. Mining is performed by contractors. **Processing:** The company owns two operating carbon-in-leach (CIL) plants, Paulsens (450ktpa) and Lakewood (1.2Mtpa, approved to 1.5Mtpa). It also owns the idle Coyote plant. **Toll treatment and ore purchase:** Lakewood processed third-party ore under toll-treatment and ore-purchase arrangements until the March 2026 quarter. This generated A$34.0M of FY26 toll and ore-purchase revenue (unaudited) [Q4-FY26]. FY27 guidance includes 4–10koz of expected third-party tolling at Lakewood [GUID-FY27]. **Sale of gold doré/bullion:** Gold is sold at spot. The company is 100% unhedged [Q4-FY26]. The refiner or offtaker is not disclosed in sources reviewed. ### Revenue model | Revenue stream | Nature | FY26 indicative scale (A$M) | |---|---|---| | Own-gold sales (spot, unhedged) | Product sale, commodity price-taker | 391.5 unaudited gold sales on 65,951oz sold at an average A$6,108/oz realised [Q4-FY26] | | Lakewood toll treatment and ore purchase | Service/processing margin plus ore-purchase arbitrage | 34.0, unaudited. The ore purchase agreement (OPA) concluded in the March 2026 quarter [Q4-FY26] | | Statutory revenue (IFRS) | Audited/reviewed total | 374.3 [4E-FY26] | There is no subscription, licensing or recurring-service revenue. The model is about 90%+ commodity product sale with a declining service (toll) component. ### Value-chain position and customers Black Cat sits upstream: exploration, mining and primary processing to doré. Its customer is effectively the bullion market, through a refiner. Its "end-markets" are global gold demand (investment, central banks, jewellery, technology). These markets are reached indirectly, so the company has no customer concentration risk in the conventional sense, but it is fully exposed to the A$ gold price. ### Company self-description The FY2025 Annual Report describes Black Cat as a fast-growing Australian gold producer. It lists operations at Paulsens and Kal East, the Coyote Gold Operation in the western Tanami, and the Mt Clement Antimony Project in the Pilbara. It frames the company as focused on building a substantial Resource business and on making the next major discovery, and it positions the stock as offering investors leverage to gold. (Paraphrased from the FY2025 Annual Report, released 29-Sep-2025.) ### Independent characterisation Black Cat is best characterised as a sub-scale, multi-asset, ramp-up-phase gold producer. Its cash engine is Paulsens, which repaid its A$106M acquisition and restart cost from operating cash flow within about 18 months of first gold [Q4-FY26]. Its main capital sink is Kal East, which has just transitioned to 100% company ore. The investment case therefore depends heavily on three things: 1. Kal East reaching nameplate grades and tonnes from Fingals and Majestic. 2. Converting Paulsens' new Regulus and Lynx discoveries into reserves. 3. The A$ gold price staying near the A$6,000+/oz levels realised in FY26. Ore Reserves (330koz) are small relative to Resources (2.5Moz). The Reserves were also estimated at stale gold prices of A$2,300–2,500/oz. Life-of-mine visibility is therefore weaker than headline Resources suggest.

Revenue$0.2B
EmployeesN/A
Market CapN/A
Founded2017
Perth, Australia
Bisalloy

Bisalloy Steel Group Limited

Premium
Information Technology

Bisalloy Steel Group is Australia's only manufacturer of quenched and tempered (Q&T) high-strength, abrasion-resistant and armour-grade steel plate, operating a stand-alone, highly automated heat-treatment facility at Unanderra, near Wollongong, with an Australian processing capacity of roughly 60,000–70,000 tonnes per annum. The company buys "greenfeed" plate mainly from neighbouring BlueScope Steel and from international suppliers including its Chinese joint venture, then quenches and tempers it into BISALLOY®-branded Wear, Structural, Armour and Protection grades. Mining and mineral processing remain the dominant end-market, but the earnings mix is shifting toward defence: Armour & Protection represented 33% of Australian revenue in FY26 (25% in FY25), Bisalloy completed the ASA's SSN-AUKUS hull-steel qualification contract, and in July 2026 it won its first US Navy Virginia-class submarine HY80 order. A 50% Chinese JV, distribution subsidiaries in Thailand and Indonesia, and the emerging OptiWear digital wear-sensor business round out a debt-free, high-payout, A$137m-revenue small-cap. --- ### Company's own description (FY26 Annual Report, paraphrased) The FY26 Directors' Report defines the Group's principal activity as the manufacture and sale of quenched and tempered, high-tensile and abrasion-resistant steel plate ("Q&T plate"), including Armour and Protection grades, alongside progress in commercialising the OptiWear digital wear-monitoring technology. The Group comprises Bisalloy Steels Pty Ltd (Australia), majority-owned distribution businesses in Indonesia (PT Bima Bisalloy) and Thailand (Bisalloy (Thailand) Co Limited), Bisalloy Digital Solutions, and an equity-accounted investment in the Chinese Joint Venture (CJV), Bisalloy Shangang (Shandong) Steel Plate Co. Ltd. The company describes itself as a proudly Australian producer of the BISALLOY® range across three main product areas — high-wear, structural and armour-grade specialty steels — and in investor materials uses the tagline that it makes products "for extreme environments." The Annual Report emphasises that the Unanderra facility is a unique stand-alone heat-treatment plant, highly automated, giving a relatively low-cost base that allows it to compete against a range of imported products. Wear and structural plate is sold through distributors and directly to select manufacturers and end users in Australia and overseas; Armour and Protection grades are exported under the Commonwealth Department of Defence's Defence Export Controls regime. ### Independent characterisation Bisalloy is best understood as a niche, value-adding steel processor rather than an integrated steelmaker. It does not make liquid steel; it buys alloyed plate ("greenfeed") and adds value through heat treatment (austenitising, water quenching and tempering), metallurgical know-how, testing/certification, and channel relationships. Its economic moat rests on four pillars: 1. **Domestic sole-producer status** — the only Q&T plate mill in Australia, giving lead-time, service and "sovereign capability" advantages over importers (SSAB, Chinese mills, Japanese and European producers). 2. **Qualification barriers in defence** — ballistic certifications (e.g., German BAAINBw/TL certification for Rheinmetall's Boxer program), the ASA SSN-AUKUS qualification (4,500+ tests), and US Navy TP300 qualification for HY80 are slow, expensive and program-specific. The company itself calls this a qualification "moat" in its March 2026 presentation. 3. **Brand and technical support** — BISALLOY®/BISPLATE® are long-established specifications in Australian mining wear applications. 4. **Proximity to supply and ports** — BlueScope's Port Kembla plate mill is within about a kilometre of the Unanderra plant. Its vulnerabilities are equally structural: it is a price-taker against imported Q&T plate (the company has repeatedly sought anti-dumping protection since 2014), it is dependent on a single greenfeed supplier (BlueScope) and a single manufacturing site, and its domestic volumes are tied to the resources capex/maintenance cycle, particularly in Western Australia and Queensland. ### Business model and revenue model | Dimension | Characterisation (FY26) | |---|---| | Revenue type | ~100% product sales. FY26 revenue: steel plate sales A$130.6m (95.6%) + shipping & handling services A$6.0m (4.4%) (FY26 AR Note 2.1) | | Service/subscription/licensing | Negligible today. OptiWear (Digital Solutions) is pitched as an asset-performance platform with recurring-revenue potential (Mar 2026 presentation) but revenue is not separately disclosed | | Recognition | Plate: point in time on transfer of control; shipping/handling: over time | | Pricing | Not disclosed; plate pricing tracks import parity, greenfeed cost, FX and grade premium | | Contract structure | Predominantly purchase orders; defence programs via qualified-supplier status and program purchase orders (e.g., GDEB ~US$2m PO, Jul 2026); ASA A$15m qualification contract (Dec 2023, completed FY26) | | Customer concentration | Top three customers = 28%, 15% and 6% of external revenue in FY26 (FY25: 30%, 17%, 2%). The first two are in the Australian segment (likely large national distributors); the third is in the overseas segment (FY26 AR Note 3) | ### Value-chain position Iron ore/coal → integrated steelmaker (BlueScope; CJV partner Shandong Steel; other international mills) → greenfeed alloy plate → Bisalloy Q&T heat treatment, testing, certification → distributors/processors (e.g., BlueScope Distribution, Orrcon, Metalcorp, independent processors; Montan Stal and MIRAS Steel in Europe) and OEMs/defence primes (Rheinmetall, Hanwha, GDEB, Newport News/HII, Israeli and other international armour manufacturers) → end users (mines, quarries, agricultural and construction equipment makers, armed forces, navies). ### Customer types and end-markets | End-market | Applications | Evidence | |---|---|---| | Mining & mineral processing | Dump-truck bodies, buckets, chutes, liners, crusher/mill wear parts | Mining = 56% of FY25 Australian industry breakdown (FY25 investor materials via FilingReader) | | Agriculture | Ground-engaging tools, implement wear parts | Named in FY26 AR as key end-user market | | Construction / infrastructure | Cranes, structural members, earthmoving | Structural grades = 35% of FY25 Australian tonnes | | Energy, oil & gas, pressure vessels | Structural/pressure applications | Mar 2026 presentation product matrix | | Defence (land) | Armoured vehicles, ballistic protection, add-on armour | Rheinmetall Boxer (LAND 400 Ph2), Hanwha AS9/AS10 Huntsman (LAND 8116), Egypt K9/K10/K11 | | Defence (naval) | Submarine pressure hull steel (HY80), frigates | Collins Class (8,000+ t), SSN-AUKUS qualification, GDEB Virginia-class order | | Government/civil protection | Security, blast/ballistic protection | Protection grades | FY25 Australian sales tonnes by product: Wear 53%, Structural 35%, Armour & Protection 12% (FY25 investor materials). By FY26, Armour & Protection accounted for 33% of Australian revenue (25% in FY25) (FY26 MD & CEO Report).

Revenue$0.1B
EmployeesN/A
Market CapN/A
Founded1980
Unanderra, Australia
Biotron

Biotron Limited

Premium
Information Technology

Biotron is a micro-capitalisation Australian drug-development company. For more than two decades it was a single-platform antiviral developer. Its scientific franchise is small-molecule antagonists of viroporins, the virus-encoded ion-channel proteins found across HIV-1, hepatitis viruses, coronaviruses, influenza and dengue. The flagship, BIT225, completed twelve clinical trials including three Phase 2 studies in 2023–24, but did not attract a licensing partner. The COVID-19 Phase 2 then missed its primary efficacy endpoint. In December 2025 Biotron diversified by acquiring Sedarex Limited. Sedarex owns SedRx, a reformulated alfaxalone general anaesthetic that the company positions as a safer, cognition-sparing alternative to propofol, on an abbreviated European/US regulatory route. Today Biotron is a virtual, outsourced R&D company with three platforms: an anaesthetic heading toward EMA engagement, a preclinical HBV/HDV candidate (BIT-HBV001), and the legacy BIT225 asset. It has no revenue, about A$1.55m in cash, a going-concern material uncertainty, and no CEO. --- **Company's own description.** Biotron describes its principal activity as funding and managing intermediate and applied biotechnology research and development projects (Annual Report FY2023, Directors' Report). Its core expertise is designing drugs against viroporins, the virus-encoded proteins that help viruses modulate and evade host immunity and sustain infection. It has built a library of compounds targeting viroporins across many human pathogens (Annual Report FY2023). Since the Sedarex acquisition, the Group describes itself more broadly as focused on new treatments for serious diseases with unmet medical needs (1H FY2026 Interim Report, Note 1). The September 2026 investor presentation frames the company as a "diversified development portfolio." That portfolio comprises SedRx, a reformulated safer general anaesthetic, plus the antiviral pipeline led by BIT-HBV001. **Business model.** Biotron is a pure pre-revenue R&D company that follows a "develop-to-license" model: - It generates clinical and preclinical data to de-risk assets. - It then seeks to license or sell them to large pharmaceutical partners for late-stage development, registration and commercialisation. The FY2023 annual report states that Phase 2 is generally the optimal licensing point. In late 2024 the company engaged US-based C14 Consulting Group LLC on a retainer-plus-success-fee basis to run partnering for the antiviral portfolio. For SedRx, management has pointed to an abbreviated regulatory route that could bring it to market faster than a new chemical entity: - an FDA 505(b)(2) pathway in the US; - an abridged or hybrid procedure in Europe. The July 2026 EMA feedback, however, complicated the Hybrid MAA route. **Revenue model mix.** **Value-chain position.** Biotron sits at the discovery and early-clinical end of the pharmaceutical value chain. It owns no laboratories or manufacturing. It outsources compound synthesis, preclinical assays (for example, HBV mouse models and cell-based assays), clinical trials (CROs in Australia and Thailand) and regulatory work (an "international regulatory advisory group" for SedRx). **Customer types and end-markets.** Biotron has no commercial customers. Its prospective counterparties are: - global and specialty pharmaceutical companies, as licensees; - in the long term, hospitals and anaesthesia services (SedRx), hepatology and infectious-disease prescribers (HBV/HDV), and HIV clinics (BIT225). **Independent characterisation.** Biotron is a sub-A$10m "option value" biotech that has pivoted, by necessity, from a mature but un-partnered antiviral platform to an in-licensed, late-stage reformulation asset. The strategic logic is defensible. Alfaxalone is a known API, SBECD is an approved excipient, and the neurocognition angle in older surgical patients is topical. Execution capacity, however, is the binding constraint: - cash covers only a few quarters at current burn; - the long-tenured CEO left in September 2026; - the board has been almost entirely replaced within twelve months.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2005
Sydney, Australia
Optima

Optima Technology Group Limited

Premium
Information Technology

Optima Technology Group, which began as BidEnergy and was later Bill Identity, was a Melbourne-based micro-cap SaaS company. It automated how multi-site enterprises collect, validate, pay and report their electricity, gas and water bills. Its core proposition was robotic process automation (RPA) applied to utility invoices. The platform extracted bill data, checked it against contract terms, tariffs and meter data, flagged exceptions before payment, and produced spend and consumption analytics. In 2022 management repositioned that data layer as an audit-grade input for Net Zero (Scope 1 and 2) emissions reporting. It rebranded the group around the 30-year-old UK Optima Energy Systems business acquired in December 2020. The company reached about A$15M of annual revenue but never achieved profitability. It burned roughly A$9–14M a year and depended on repeated equity raises. A customer loss (Origin Energy), falling equity values and an exhausted funding path led to administration in July 2023, liquidation and delisting. --- ### Company's own description (FY2022 Annual Report, paraphrased) The FY2022 Directors' Report described the principal continuing activities as those of a software technology company. It offered accurate, automated and secure energy data management solutions focused on Net Zero reporting, bill management and procurement planning. In the United States only, the group also earned fees from a rebate business. That business managed the submission of information to energy retailers so that clients could claim rebates under energy-efficiency infrastructure programs. ### Independent characterisation The business was best understood as three economically distinct activities sharing one corporate shell: 1. **Utility Bill Management (UBM) SaaS, ANZ.** This was the original BidEnergy platform. It sold to large multi-site enterprises directly and through white-label channel partners, notably Origin Energy from 2019 to 2023. Revenue was recurring platform subscription fees. Gross margins were modest for SaaS (about 44–45%), which shows that a meaningful human exception-handling layer sat behind the "automation". 2. **Energy data management SaaS, UK/EU.** This was the Optima Energy Systems business (founded 1988, Skipton, Yorkshire), acquired December 2020. Its long-tenured software served large end users and energy consultants for bill validation, data loading and contract analysis. Gross margin was about 49–51%. 3. **US energy-efficiency rebate administration.** This was RealWinWin (Philadelphia), acquired November 2016. It was a transactional, success-fee service with high margins (about 76–84% gross margin) and lumpy, project-dependent revenue. It was classified as non-core in FY2022 and sold in November 2022. A fourth activity, US UBM platform contracts, was shut down between December 2021 and May 2022. About 20 contracts with negative or low gross profit were exited and reported as a discontinued operation (A$3.29M loss in FY2022). ### Business and revenue model | Revenue stream | Model | FY2022 revenue (A$'000) | Share of continuing revenue | Source | |---|---|---|---|---| | Platform subscription fees (ANZ + UK/EU) | Recurring SaaS subscription, recognised over service period | 11691 | 80.1% | FY2022 Annual Report | | US energy rebate fees | Success / transaction fees, recognised when rebate cash received from utilities | 2910 | 19.9% | FY2022 Annual Report | | Non-subscription energy spend review services | Project services, percentage-of-completion | Not separately disclosed | n/a | FY2022 Annual Report (accounting policy) | | Micro-service licensing (data extraction / validation, US) | Licensing | Not separately disclosed | n/a | FY2022 Annual Report (strategy narrative) | **Mix assessment (FY2022):** about 80% subscription and 20% transactional services. There were no meaningful hardware or perpetual-licence revenues. ### Value-chain position The company sat between energy suppliers (retailers and utilities), which issue invoices and meter data, and corporate energy buyers' accounts payable, procurement and sustainability teams. Its main distribution partners were energy retailers (Origin, Simply Energy), energy brokers and consultants, and professional-services firms. It did not own meters, trade energy or carry retail licences. ### Customer types and end-markets **Customers:** Multi-site enterprises, including telcos (Singtel Optus), not-for-profits (The Salvation Army), US conglomerate units (Berkshire Hathaway business, US), a large US retailer with over 850 stores, BP (UK/EU), and energy retailers' commercial and industrial (C&I) portfolios. **Scale indicators:** 92 clients and more than 85,000 meters at 30 June 2019 (Canaccord via FNArena). The Optima UK acquisition added 51 customers and more than 196,000 meters (December 2020, iTWire). Group marketing in 2022 claimed more than 530,000 meters and over £4.9bn of spend under management across six countries (Energy Live News sponsor profile). **End-markets:** Corporate energy and utility spend management; ESG / Net Zero emissions data and reporting; US utility energy-efficiency incentive programs.

RevenueN/A
EmployeesN/A
Market CapN/A
Founded2008
Melbourne, Australia

Page 227 of 482

1…226227228…482

Page 227 of 482

Go to page
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo